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Abstract 
Recoding embraces mechanisms that augment the rules of standard genetic 
decoding. The deviations from standard decoding are often purposeful and their 
realisation provides diverse and flexible regulatory mechanisms. Recoding events 
such as programed ribosomal frameshifting are especially plentiful in viruses. In 
most organisms only a few cellular genes are known to employ programed 
ribosomal frameshifting in their expression. By far the most prominent and therefore 
well-studied case of cellular +1 frameshifting is in expression of antizyme mRNAs. 
The protein antizyme is a key regulator of polyamine levels in most eukaryotes with 
some exceptions such as plants. A +1 frameshifting event is required for the full 
length protein to be synthesized and this requirement is a conserved feature of 
antizyme mRNAs from yeast to mammals. The efficiency of the frameshifting event 
is dependent on the free polyamine levels in the cell. cis-acting elements in antizyme  
mRNAs such as specific RNA structures are required to stimulate the frameshifting  
efficiency. Here I describe a novel stimulator of antizyme +1 frameshifting in the  
Agaricomycotina class of Basidiomycete fungi. It is a nascent peptide that acts from  
within the ribosome exit tunnel to stimulate frameshifting efficiency in response to  
polyamines. The interactions of the nascent peptide with components of the peptidyl  
transferase centre and the protein exit tunnel emerge in our understanding as 
powerful means which the cell employs for monitoring and tuning the translational 
process. These interactions can modulate the rate of translation, protein co-
translational folding and localization. Some nascent peptides act in concert with 
small molecules such as polyamines or antibiotics to stall the ribosome. To these 
known nascent peptide effects we have added that of a stimulatory effect on the +1 
frameshifting in antizyme mRNAs. It is becoming evident that nascent peptide 
involvement in regulation of translation is a much more general phenomenon than 
previously anticipated. 
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Chapter 1 
Augmented Genetic Decoding: global, local and 
temporal alterations of decoding processes and 
codon meanings.  
 
This chapter has been published as a review on Recoding in Nature Reviews 
Genetics 16, 517–529 (2015)  
 
The non-universality of the genetic code is now widely appreciated. Codes differ 
between organisms, and certain genes are known to alter the decoding rules in a site-
specific manner. Recently discovered examples of the decoding plasticity are 
particularly spectacular. These include organisms and organelles with disruptions of 
triplet continuity during translation of many genes, viruses altering the entire genetic 
code of their hosts and organisms adjusting their genetic code in response to 
changing environment. In this Review we outline various modes of alternative 
genetic decoding and introduce some novel terminology to accommodate recently 
discovered manifestations of this seemingly sophisticated phenomenon. 
 
1.1   Introduction 
 
The famous Jacob Monod phrase “Anything found to be true of E. coli must also be 
true of elephants” reflects the prevalent mindset of biochemists and molecular 
biologists at the time when the genetic code was being deciphered. Indeed, the 
chemistry and molecular mechanisms of genetic information inheritance and its 
decoding from nucleic acids into proteins were seemingly the same for all forms of 
life. This culminated in Francis Crick’s ‘frozen accident’ hypothesis for the origin of 
the genetic code (Crick, 1968) according to which the genetic code (Fig. 1.1a) is not 
only universal, but also unchangeable and unevolvable. Ironically, the time of the 
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hypothesis formulation also marked the beginning of series of experimental 
observations of various exceptions from what is known as the standard rules of the 
genetic decoding, leading to a ‘melting’ in perceptions of the universality of the 
genetic code (Riyasaty and Atkins, 1968, Weiner and Weber, 1971, Barrell et al., 
1979, Yamao et al., 1985, Horowitz and Gorovsky, 1985, Preer et al., 1985, Clare 
and Farabaugh, 1985, Jacks and Varmus, 1985, Mellor et al., 1985, Chambers et al., 
1986, Craigen and Caskey, 1986, Huang et al., 1988, Matsufuji et al., 1995, Keiler et 
al., 1996, Srinivasan et al., 2002, Jungreis et al., 2011, Prat et al., 2012, Lang et al., 
2014) (Fig. 1.1b). 
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Figure 1.1 Freezing and melting of genetic decoding. a. The standard genetic 
code. b. A timeline illustrating major events that shaped current understanding of 
genetic decoding. The early discoveries that led to the formulation of universal 
principles of genetic decoding are shown in blue. The more recent findings that 
revealed evolvability and flexibility of genetic decoding are shown in red. 
 
By now we are aware of more than twenty natural variant genetic codes 
(Knight et al., 2001)  and it is very likely that there are more to discover. Two non-
universal proteinogenic amino acids (Selenocysteine (Chambers et al., 1986) and 
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Pyrrolysine (Srinivasan et al., 2002)) have been discovered in addition to the 20 in 
the standard genetic code, and the possibility that more exist cannot be dismissed 
(Ambrogelly et al., 2007). Numerous mRNAs have evolved special sequence 
elements to alter the meaning of specific codons or to make ribosomes shift reading 
frame or even to bypass long untranslated regions (Atkins and Gesteland, 2010). 
Alterations in genetic decoding are expected to exist in virtually all organisms, 
bioinformatics screens of bacterial genomes are revealing thousands of genes whose 
decoding requires ribosomal frameshifting (Sharma et al., 2011, Antonov et al., 
2013b, Antonov et al., 2013a) and metagenome analyses of environmental samples 
point to many organisms with variant genetic codes (Ivanova et al., 2014).  
Nature also continues to surprise us with novel types of alternative genetic 
decoding. The most recent discoveries pose provocative questions and suggest 
heretical ideas: Could an organism’s genetic code change during the organism’s 
lifetime? Could a parasite hijack the genetic code of its host? Could there be genetic 
codes with non-triplet features? In this Review we will give a brief overview of the 
known classes of alternative genetic decoding and their implications for entire 
genomes or individual mRNAs (Table 1.1). We will start with global changes of 
codon meaning on the scale of the entire genetic code (codon reassignments) and 
continue with local changes specific to particular sites in particular mRNAs (codon 
redefinition). Then we will describe processes that disrupt the continuity of triplet 
decoding, such as ribosomal frameshifting and translational bypassing. Along the 
way we will expand existing terminology to accommodate the growing complexity 
of the phenomenon of alternative genetic decoding. 
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What is 
affected?
‡
 
(individual 
codons, 
protein length 
or both) 
Competes 
with 
standard 
translation 
in a 
concurrent 
or temporal 
manner?
¶
 
Examples 
G
en
o
m
ic
 d
is
tr
ib
u
ti
o
n
*
 
G
lo
b
a
l 
Sense codon  
No Codon reassignments that lead to variant genetic codes, see 
http://www.ncbi.nlm.nih.gov/Taxonomy/Utils/wprintgc.cgi 
Yes Decoding of CUG as serine and leucine in some Candida species 
(Ohama et al., 1993) 
Stop codon  
(Protein 
length is 
affected) 
No Codon reassignments that lead to variant genetic codes, see 
http://www.ncbi.nlm.nih.gov/Taxonomy/Utils/wprintgc.cgi 
Yes 
The meaning of UAG as a stop or Pyl in the genetic code  
of A. arabaticum is dependent on the energy source (Prat et al., 2012).  
During infection a phage-encoded RF2 alters the genetic code of its host 
(Ivanova et al., 2014). 
Protein length No/Yes 
Ribosomal frameshifting in ciliates of the Euplotes genus 
(Klobutcher and Farabaugh, 2002) and translation bypassing in  
mitochondria of M. capitatus(Lang et al., 2014) are pervasive.  
However, it is not yet clear whether these processes are in  
competition with standard translation. 
 
L
o
ca
l 
Sense codon 
No No known natural examples. 
Yes Selenocysteine insertion in Euplotes species 
(Turanov et al., 2009). 
Stop codon 
(Protein 
length is 
affected) 
No 
Selenocysteine insertion at mRNAs encoding selenoproteins 
 with multiple selenocysteine residues is likely to be highly  
efficient(Hill et al., 1991, Lobanov et al., 2008). 
Yes 
Selenocysteine insertion, stop-codon readthrough 
Protein length 
No No known natural examples. 
Yes Ribosomal frameshifting, translational bypassing 
 
Table 1.1 Classification of different types of alternative genetic decoding events.  
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*Alternative decoding may affect expression of all or most genes within a genome 
(globally distributed) or only a subset of individual mRNAs that bear specific 
stimulatory elements (local events).  
‡
An alternative decoding event may alter the meaning of a single codon with no 
effect on downstream codons. It also can alter the length of protein sequence by 
combining protein sequences encoded in overlapping or disjointed open reading 
frames (ORFs). A change of codon meaning from stop to sense ultimately creates an 
elongated proteoform. 
¶
The alternative decoding event could occur in competition with standard 
translation (concurrent or temporal) or be a principal process. 
 
1.2   Global codon reassignment 
 
1.2.1 Variant genetic codes resulting from fixed codon reassignments.  
 
At the moment of writing the NCBI Genetic Code database 
(http://www.ncbi.nlm.nih.gov/Taxonomy/Utils/wprintgc.cgi) provides a list of 21 
distinct genetic code tables. Examination of these tables reveals two patterns: high 
abundance of mitochondrial variant codes and fixed codon reassignment involving 
stop codons. The only known non-mitochondrial sense codon reassignment is a 
CUG codon change from Leu to Ser in some yeast of the Candida genus (Ohama et 
al., 1993). The prevalence of mitochondrial reassignments is most likely due to the 
small number of potentially affected genes, but also due to properties of 
mitochondria and chloroplasts that are discussed in section 1.2.4. The prevalence of 
stop codon reassignment is due to the naturally infrequent occurrence of stop codons 
and their comparatively high evolutionary flexibility, as discussed in section 1.2.3. 
1.2.2 Alterations to molecular machineries required for codon reassignment.  
 
The global rules of genetic decoding are defined by the molecular components of the 
translation machinery. Recognition of sense codons and stop codons differ. Whether 
a particular sense codon is decoded as a specific amino acid depends on two 
molecules, a tRNA that recognizes that codon and an aminoacyl-tRNA synthetase 
(aaRS) that charges the tRNA with the amino acid (Fig. 1.2). Therefore, a change of 
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sense codon standard meaning should involve either modification of existing tRNAs 
and/or aaRSs or their loss or gain through gene duplications or horizontal gene 
transfer. 
Stop codons are recognized by class I release factor proteins (RF) that 
directly interact with mRNA inside the ribosome and trigger hydrolysis and release 
of the nascent peptide. Thus, which codon is recognized as a stop primarily depends 
on the structure of the RF proteins, and lack of competition from cognate tRNAs. In 
most bacteria and organelles, there are two release factors that recognize stop 
codons semi-specifically: UGA and UAG are each recognized only by one 
specialized factor while UAA is recognized by both (Duarte et al., 2012). All known 
cases of codon reassignment in bacteria involve a loss of RF2, which recognizes 
UGA codons. This may not be accidental: a recent study of a large number of 
metagenomic sequences revealed many bacterial genes with reassigned stop codons 
which are exclusively UGA codons, suggesting that RF1 unlike RF2 may be 
indispensable for bacteria in the wild (Ivanova et al., 2014). In the majority of 
characterized cases UGA is reassigned to code for Trp (Yamao et al., 1985, Bove, 
1993, McCutcheon et al., 2009), but in uncultured SR1 bacteria found in marine and 
fresh-water environments as well as in human microbiota, UGA was recently shown 
to encode Gly (Campbell et al., 2013, Ivanova et al., 2014). 
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Figure 1.2: Components that shape alternative genetic decoding. The scheme 
illustrates a distinction between codon reassignment and recoding which are 
sometimes confused in the literature. Collective representation (assembled from 
several examples from different organisms) of stop codon reassignment (part a) and 
recoding (part b) is shown. Different ways by which codon meaning can be 
reassigned as exemplified by the AGA codon. It is known to have four different 
meanings depending on the variant genetic code used in the corresponding 
organism. It can originate as a result of changes in tRNAs, aaRSs or release factors 
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(RFs), though may involve other components as exemplified with AGA reassignment 
to stop codon in vertebrate mitochondria, see the main text. Codon reassignment 
affects the expression of all genes in the organism that use the reassigned codon. b | 
Two recoding events are shown. Codon redefinition (left) is exemplified with a 
schematic of selenocysteine (one-letter amino acid abbreviation U) insertion at 
UGA codons in eukaryotes, which requires a selenocysteine insertion sequence 
(SECIS) element in the 3’ UTR, a specialized tRNA, an elongation factor eEFSec 
and auxiliary protein SECIS-binding protein 2 (SBP2). Ribosomal frameshifting 
(right) is shown as a collective representation of several frameshifting events. 
Shine–Dalgarno interactions with ribosomal RNA stimulate frameshifting in 
bacterial release factor 2 mRNA decoding. A stimulatory downstream RNA 
pseudoknot structure is present in many eukaryotic antizyme mRNAs. Frameshifting 
in antizyme is also known to be sensitive to the concentrations of polyamines. These 
examples illustrate how (in contrast to codon reassignment), recoding events are 
dependent on favorable sequence contexts that locally alter the interpretation of the 
codon sequences. 
 
1.2.3 Decoding plasticity in mitochondria. 
 
Global alterations of genetic decoding are frequent in mitochondria. Most known 
codon reassignments are found in mitochondria (Knight et al., 2001), and pervasive 
translational bypassing of byps elements was also discovered in mitochondria (Lang 
et al., 2014). Why are mitochondria so prone to changes of their genetic decoding? 
There could be several explanations, which are not mutually exclusive. 
 First, mitochondrial genomes are very small: transfer of genetic material 
between mitochondrial and nuclear genomes predominantly occurs in one direction 
(Timmis et al., 2004) leading to extreme mitochondrial genome reduction. The 
genetic code used for decoding a small genome is easier to modify because a change 
in a codon meaning would affect fewer codons and fewer genes. Second, 
endosymbiosis isolated mitochondria from the outer world, making horizontal gene 
transfer (HGT) to mitochondria an extremely unlikely event. Free-living 
microorganisms could use HGT to improve their genomes to suit particular 
environments by obtaining genetic material from other inhabitants of the same 
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environment. However, to use the foreign genetic material, the recipient needs to use 
the same genetic language as the donor. This may create evolutionary pressure to 
maintain a universal genetic code. This pressure is unlikely to exist for organelles 
that could not use HGT. Third, mitochondrial genome evolution is asexual, thus 
there is no mechanism for eliminating mildly harmful mutations in contrast to 
evolution that involves sexual reproduction (Kondrashov, 1988). All these features 
allow for increased diversity of the molecular processes among mitochondria of 
different organisms. However, some specific codon reassignments in mitochondria 
may also be beneficial. AUA reassignment from isoleucine to methionine occurred 
independently at least twice during eukaryotic evolution (Lang et al., 2014). The 
resultant increase of methionine content in the mitochondrial proteome may provide 
mitochondria with protection from its highly oxidative environment (Bender et al., 
2008). 
 
1.2.4 Evolutionary routes to codon reassignment.  
 
There are several non-mutually exclusive models for the process of codon 
reassignment (Knight et al., 2001). The codon capture model (Osawa and Jukes, 
1989) involves disappearance of a rare codon accompanied by loss or change of 
function of its decoder (e.g. UGA and RF2). The next step is reappearance of the 
codon and its preferential decoding by a different molecule (e.g. near-cognate 
reading of UGA by tryptophan tRNA, for which the cognate codon is UGG), 
followed by optimization of the new decoding. This model is supported by the 
existence of organisms with exceptionally rare codons where expression of the 
corresponding tRNAs is inessential for growth, e.g. UUA in some Streptomyces 
species (Chater and Chandra, 2008). An example of extreme codon scarcity is the 
CGG codon that occurs just once in all protein coding genes of Candidatus 
Carsonella ruddii (Nakabachi et al., 2006). 
 The ambiguous intermediate hypothesis (Schultz and Yarus, 1996) proposes 
the existence of an intermediate ambiguous state, where a codon has two meanings. 
A classic example of an ambiguous state is in Candida albicans where the CUG-
decoding tRNA can be aminoacylated by either seryl-tRNA synthetase or leucyl-
tRNA synthetase. As a result Leu and Ser are distributed stochastically in the 
 18 
 
Candida proteome at the positions corresponding to CUG codons (Suzuki et al., 
1997, Santos et al., 1997).  Ambiguous decoding can be beneficial. In response to 
oxidative stress in mammalian cells, specific phosphorylation of methionyl-tRNA 
synthetase leads to increased methionylation of non-cognate tRNAs, which increases 
the amount of methionine in the proteome for protection against reactive oxygen 
species (Netzer et al., 2009, Lee et al., 2014). A recent example of bacteria that uses 
two different genetic codes depending on the carbon source is described below. It 
suggests that a transition from one code to the other does not require a walk through 
a valley of low fitness as can be imagined in the case of ambiguous decoding 
leading to the synthesis of presumably harmful aberrant proteins. On the contrary, 
the organisms could have increased fitness in an environment with oscillating 
conditions by altering their proteomes to suit the changes. A scenario is plausible in 
which an organism evolves a regulated genetic code in response to a changing 
condition and fixes the new variant once the new condition becomes stable. 
 
1.2.5 Regulated codon reassignment.  
 
Pyrrolysine is one of the two non-universal proteinogenic amino acids (the other is 
selenocysteine) not specified by the standard genetic code. Pyrrolysine is found in 
methanogenic bacteria and archaea (Srinivasan et al., 2002) and is incorporated at 
UAG codons. Unlike selenocysteine incorporation (see below), pyrrolysine 
incorporation uses standard elongation factors and does not require a specialized 
RNA structure for its incorporation (Namy et al., 2007), although it has been 
reported that in certain contexts an RNA structure affect the efficiency of 
pyrrolysine incorporation (Longstaff et al., 2007).  
Extreme scarcity of UAG codons and alterations in the mRNA recognition 
domain of release factors in methanogenic archaea suggest that UAG is not an 
efficient stop codon and is mostly used for constitutive incorporation of pyrrolysine 
(Zhang et al., 2005). The frequency of UAG codons in pyrrolysine-utilizing bacteria 
is much higher and similar to that of other stop codons. Moreover, as both release 
factors are present, UAG is expected to be recognized as a stop codon.   
A recent discovery (Prat et al., 2012) provides a clue to why certain bacteria 
maintain UAG as a codon for pyrrolysine and as an efficient stop codon. 
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Acetohalobium arabaticum, which lives in a saline marine environment, can utilize 
several different sources of energy including trimethylamine (King, 1988). When 
trimethylamine is available, A. arabaticum expresses an operon required for 
pyrrolysine incorporation, while in the absence of trimethylamine its expression is 
turned off. Thus, A. arabaticum is capable of regulating the meaning of UAG codon 
in response to environmental conditions (Prat et al., 2012). This marvelous example 
illustrates the ability of an organism to change its genetic code by using regulated 
codon reassignment without rewiring its genome.  
 Another startling example of a regulated genetic code has been proposed in a 
large metagenomic study of stop codon reassignments, which identified a 
bacteriophage that encodes RF2 in its genome as well as a tRNA that recognizes 
UAG codons (Ivanova et al., 2014). These bacteriophages infect bacteria lacking 
RF2 (with UGA being a sense codon). During the early stage of infection the virus 
expresses genes using the host genetic code where UGA is sense and UAG specifies 
a stop). During the later stage of infection when the virus needs to shut off host 
protein synthesis and redistribute the cell’s resources to viral particle production, the 
virus expresses its RF2 and UAG-recognizing tRNA genes, thus changing the 
genetic code to one where UGA is a stop and UAG is a sense codon (Ivanova et al., 
2014). 
1.3   Local codon redefinition 
 
The meaning of a codon can be changed in the context of a specific mRNA or at a 
specific location within the mRNA. To distinguish it from codon reassignment, this 
phenomenon is often termed codon redefinition and is considered to be a class of 
recoding events (Atkins and Baranov, 2010) (see Fig. 1.2 for a visual distinction). 
Naturally, because codon redefinition takes place in the context of a single or of a 
subset of mRNAs, these mRNAs should have specific properties or sequence 
elements that distinguish them from the other mRNAs.  
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1.3.1 Stop codon readthrough. 
 
Stop codon readthrough is useful when there is a need to synthesize proteoforms 
with variant C-terminal ends from the same mRNA (Fig. 1.3). Such a situation is 
highly beneficial for viruses in which stop codon readthrough can be used to 
economically encode a second product with a C-terminal extension (see refs (Firth 
and Brierley, 2012, Dreher and Miller, 2006) for reviews). Until recently, stop 
codon readthrough was reported only in a very small number of cellular 
chromosomal genes (Steneberg and Samakovlis, 2001, Namy et al., 2003, Namy et 
al., 2002, Robinson and Cooley, 1997, Klagges et al., 1996). However, emerging 
evidence indicates that stop codon readthrough can be abundant during cellular gene 
translation. Phylogenetic analysis of protein coding genes in 12 Drosophila species 
revealed that sequences downstream of annotated stop codons have evolved under 
constraints of protein-coding selection in almost 300 genes (Jungreis et al., 2011). 
This indicates that the encoded protein rather than the nucleotide sequences of these 
regions are important for fruit fly fitness and therefore these sequences are likely to 
be translated during certain stages of the Drosophila life cycle. These predictions 
were confirmed by ribosome profiling experiments that revealed an even larger 
number of Drosophila genes with detectable stop codon readthrough (Dunn et al., 
2013). While frequent stop codon readthrough in these species may be an exception, 
the number of human genes with documented stop codon readthrough is also 
growing (Loughran et al., 2014, Eswarappa et al., 2014, Schueren et al., 2014, 
Stiebler et al., 2014).    
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Figure 1.3: Relationship between nucleotide sequences and alternatively decoded 
proteins. Nucleotide sequences are represented as three horizontal boxes 
representing three different reading frames. Start and stop codons are shown as 
vertical lines; green for starts and red for stops. The sequences translated into 
proteins are shown as horizontal bars with N- and C-terminal ends indicated. The 
purple bars correspond to standard decoding and orange corresponds to alternative 
events. Transitions between reading frames are denoted with broken lines. 
 
Translational termination is slower and less accurate than elongation. 
Moreover, its efficiency and accuracy are context dependent (Pavlov et al., 1998, 
Bonetti et al., 1995, Namy et al., 2001). Thus, low-efficiency stop codon 
readthrough can be achieved in the absence of any sophisticated stimulatory 
structures. Sequence constraints as short as six nucleotides downstream of a stop 
codon are sufficient to achieve a readthrough efficiency that is significantly higher 
than background levels (Skuzeski et al., 1991).  Selection for a weak termination 
context downstream of stop codons is evident among many stop codon readthrough 
genes; however, a higher efficiency of readthrough often involves additional 
elements such as RNA secondary structures (Firth et al., 2011). 
 
1.3.2 Selenocysteine incorporation 
 
Selenocysteine (Sec) is one of the two non-universal proteinogenic amino acids and 
its incorporation into proteins is another type of codon redefinition. Selenocysteine 
is specified by UGA codons and as with stop codon readthrough this results in 
synthesis of a protein with a C-terminal extension relative to the corresponding open 
reading frame (ORF) (Fig. 1.3). However, synthesis of different lengths of 
alternative proteoforms is not the main purpose of selenocysteine incorporation as 
only the longest proteoforms are believed to be functional. Rather, selenocysteine is 
often incorporated into the catalytic centres of certain enzymes to improve their 
biochemical properties (Lee et al., 2000, Zhong et al., 2000).  
The mRNAs of selenoproteins are specified by a special RNA secondary 
structure, known as a SECIS (SEC Insertion Sequence) element. The structure of 
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SECIS elements and their location differ between bacteria and eukaryotes. They 
occur within the coding region of mRNAs in bacteria (Heider et al., 1992), but in the 
3’ untranslated regions (UTRs) in eukaryotes (Berry et al., 1993), although yet 
another auxiliary structure (the Sec codon redefinition element (SRE)) occurs within 
the coding regions of some eukaryotic selenoprotein-encoding mRNAs (Howard et 
al., 2005, Howard et al., 2007).  
The SECIS element is obviously insufficient for this process to take place in 
any organism. The organism needs to also be able to synthesize Sec and to 
incorporate it into proteins. These steps involve expression of a number of genes, 
including those coding for a specialized Sec-tRNA, as well as specialized elongation 
factors that bring Sec-tRNA to the ribosome and auxiliary factors that allow the 
recruitment of the Sec-tRNA to only SECIS-containing mRNAs (see refs (Squires 
and Berry, 2008, Driscoll and Copeland, 2003, Labunskyy et al., 2014, Yoshizawa 
and Bock, 2009, Rother et al., 2001) for reviews). Acquisition of the selenocysteine 
machinery in bacteria is conceivably due to frequent horizontal gene transfer from 
bacteria in which the required genes are organized on a single operon (Gursinsky et 
al., 2000). In eukaryotes, spontaneous simultaneous transfer of all genes required for 
selenocysteine specification is unlikely; therefore, the predominant mode for this 
trait’s evolution is its loss, as evident in certain yeast, nematodes (Otero et al., 2014) 
and insects (Chapple and Guigo, 2008).  
The decoding of UGA as a selenocysteine is not 100% efficient, although it 
is expected to be highly efficient in selenoprotein P mRNA where selenocysteine is 
incorporated at multiple locations (Hill et al., 1991). For example, selenoprotein P in 
sea urchin has 28 selenocysteine residues (Lobanov et al., 2008). If we assume that 
the efficiency of selenocysteine incorporation at each UGA is 90%, only about 5% 
(0.9
28
) of the ribosomes translating selenoprotein P mRNA would be able to 
synthesize the full length protein, while the rest would terminate on one of the 28 
UGA codons. Therefore, it has been hypothesized that Sec incorporation is 
inefficient only at the first UGA codon. Sec incorporation at this codon might serve 
as a checkpoint for the availability of factors required for selenocysteine 
incorporation. The efficiency of all subsequent Sec incorporations would be close to 
100% (Berry and Howard, 2010).  
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The sensitivity of Sec incorporation to the availability of selenium varies 
among different selenoprotein mRNAs (Howard et al., 2005). This allows the 
synthesis of particularly important selenoproteins at the expense of less important 
ones under conditions of selenium deficiency. Interestingly, the same selenocysteine 
insertion machinery can be used to incorporate standard cysteine at UGA codons, 
albeit inefficiently (Xu et al., 2010). This mechanism provides the possibility to 
synthesize some levels of a full-length but Sec-depleted variant of a ‘selenoprotein’ 
even in the absence of selenium. Although less active, enzymes with a cysteine 
instead of selenocysteine retain some activity (Lee et al., 2000, Zhong et al., 2000). 
An inefficient enzyme is better than no enzyme at all.  
Selenocysteine is not always specified by a stop codon. In ciliates of the 
genus Euplotes, which possess the selenocysteine machinery, the UGA stop codon is 
reassigned to code for cysteine (Hoffman et al., 1995). Despite this reassignment, 
the SECIS structure in the 3’ UTR of Euplotes mRNA can, at UGA codons in 
specific locations in mRNAs, direct a proportion of the ribosomes to insert 
selenocysteine instead of cysteine in the growing polypeptide (Turanov et al., 2009).  
Clearly, UGA did not evolve to encode selenocysteine after being globally 
reassigned to a sense codon in Euplotes. In an ancestor of Euplotes with UGA 
specifying a stop, UGA was redefined to specify selenocysteine and only then UGA-
stop was reassigned to UGA-Cysteine in the entire genetic code. Therefore, even 
this seeming sense-to-sense codon redefinition is a product of two evolutionary 
events, both involving a modification of stop codon meaning (BOX 2). Yet it 
provokes a question whether other sense-to-sense codon redefinition may exist. It is 
comparatively simple to find codon redefinition events that involve stop codons due 
to their dramatic effect on the decoded products (Fig. 1.3). It is easier to detect 
protein products for which size is substantially altered; it is also possible to use 
phylogenetic approaches for finding cases of stop codon redefinition as the 
nucleotide sequence downstream of the redefined stop codons is likely to exhibit 
signatures of protein-coding evolution (Jungreis et al., 2011). Sense-to-sense codon 
redefinition in Euplotes was discovered primarily to satisfy scientific curiosity 
regarding how selenocysteine is incorporated in Euplotes where UGA is not a stop 
codon, hence the investigators knew exactly where to look (Turanov et al., 2009). If 
there are other cases of sense-to-sense codon redefinition, we do not know where to 
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look for them. It is unclear what would be the benefit of redefining the meaning of a 
codon from one standard amino acid to another standard amino acid at a single 
position of a specific mRNA if this could be accomplished with often less than three 
point mutations. The benefit of sense codon redefinition is obvious only in case of 
incorporation of non-universal proteinogenic amino acids. While we cannot exclude 
the possibility that there is a 23
rd
 proteinogenic amino acid (Ambrogelly et al., 
2007), so far it has not been found (Lobanov et al., 2006, Fujita et al., 2007). 
 
1.4   Ribosomal frameshifting 
 
Irrespective of the meaning of individual codons in a variant genetic code, most 
proteins in all modern organisms are expected to be decoded as uninterrupted 
sequences of nucleotide triplets, with no gaps or overlaps between the codons. 
Ribosomal frameshifting (Fig. 1.3) is often described as programmed ribosome 
frameshifting (PRF) when it occurs at a specific location of mRNA, implying that 
the sequence of mRNA “programs” frameshifting to occur. There is a minority of 
genes whose expression requires PRF for the synthesis of encoded proteins. 
Frameshifting may also affect expression of other genes that encode proteins in the 
standard triplet manner. In this case the synthesis of encoded full-length protein 
would be abolished.  Because of the opposing effects of frameshifting on gene 
expression, we propose that productive PRF and abortive PRF need to be 
distinguished and separately defined, therefore we describe them in different 
subsections below.   
1.4.1 Productive PRF 
 
The requirement for ribosomal frameshifting is especially common in viral decoding 
where it is sometimes used for the same purpose as stop codon readthrough, i.e. to 
generate proteoforms with alternative C-termini and different functional properties.  
Due to the sensitivity of ribosomal frameshifting to cellular conditions, often 
it is used for regulatory purposes. In this case, synthesis of a functional product 
depends on ribosomal frameshifting, whereby the product of standard translation is 
usually dysfunctional and the efficiency of frameshifting is regulated. One such 
example is decoding of bacterial release factor 2 (RF2) mRNA, for which the 
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product of its translation, the RF2 protein, inhibits frameshifting and thus 
downregulates its own expression through a negative feedback loop (Craigen and 
Caskey, 1986). This mechanism is highly conserved and operates in the vast 
majority of bacteria (Baranov et al., 2002b, Bekaert et al., 2006). In eukaryotes, 
frameshifting in antizyme mRNAs is dependent on the concentration of polyamines 
(Matsufuji et al., 1995) whose synthesis and uptake is regulated by antizyme 
proteins, and the mechanism operates in all sequenced antizyme genes with the 
exception of antizyme in Tetrahymena (Ivanov and Atkins, 2007). Recently it was 
discovered that in some bacteria the mechanism of the response to antibiotics also 
involves frameshifting (Gupta et al., 2013).   
Thus far, numerous examples of productive PRF are well documented and 
extensively studied and, perhaps, can be found in all or almost all organisms (see 
refs (Cobucci-Ponzano et al., 2012, Firth and Brierley, 2012, Dinman, 2012, 
Baranov et al., 2002a, Baranov et al., 2006, Atkins and Gesteland, 2010, Farabaugh, 
1997, Namy et al., 2004) for selected comprehensive reviews). However, recent 
years have been particularly fruitful for discovering novel cases of productive PRF 
due to the abundance of sequenced genomes, which allowed for powerful 
comparative sequence analyses. These comparative analyses can provide clear 
evidence of frameshifting functionality by detecting purifying evolutionary selection 
acting on either the sequence that is required for efficient ribosomal frameshifting or 
the protein-coding region that requires upstream frameshifting for its expression 
(Firth et al., 2010a). This approach permitted the identification of a number of novel 
‘hidden’ genes in viruses that require a frameshifting event for their expression 
(Jiang et al., 2014, Fang et al., 2012, Loughran et al., 2011, Firth et al., 2010b, 
Melian et al., 2010, Firth and Atkins, 2009, Firth et al., 2008) including one in 
influenza A (Firth and Brierley, 2012, Jagger et al., 2012).  
Similar analyses of bacterial genomes revealed numerous genes that are 
under the control of ribosomal frameshifting; these genes occur predominantly in 
transposable elements and prophages (Antonov et al., 2013b, Antonov et al., 2013a, 
Sharma et al., 2011). As in bacteria, the majority of eukaryotic nuclear genes that are 
known to utilize frameshifting in their expression are in transposable elements, or 
their derivatives (Gao et al., 2003). In humans, for example, only five genes that 
require frameshifting for their expression are currently known: three antizyme 
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paralogues (OAZ1, OAZ2 and OAZ3) (Ivanov and Atkins, 2007) and two 
transposon-derived genes PEG10 (Shigemoto et al., 2001) and PNMA3 (Wills et al., 
2006). While it is likely that many cases of productive PRF are undiscovered, it is 
also likely that productive PRF is very rare among non-mobile chromosomal genes 
in most organisms (although see below for a noticeable exception involving 
pervasive frameshifting in Euplotes). For instance, comparative sequence analysis of 
insect genomic sequences revealed only four genes with overlapping coding regions 
that might be expressed through PRF (Lin et al., 2007). Only one of these genes, 
encoding a homologue of the human tumour suppressor adenomatous polyposis coli 
(APC), was confirmed to use ribosomal frameshifting for the expression of an 
alternative proteoform (Baranov et al., 2011). Ribosome profiling technique (ribo-
seq) (Ingolia, 2014) allows determination of the positions of the translating 
ribosomes on mRNA in vivo and with sub-codon resolution. Thus, it can be used for 
detecting what reading frame is translated in mRNA. Ribo-seq data obtained in yeast 
and in human cultured cells did not reveal abundant occurrence of ribosomal 
frameshifting, although it confirmed some of the previously identified cases and 
revealed a number of sequences that are translated in more than one frame (Michel 
et al., 2012). Low sequence coverage in early ribo-seq data limited the predictive 
power of this work; perhaps future applications of similar methods will become 
more fruitful at identifying novel instances of ribosomal frameshifting. 
 
1.4.2 Abortive PRF 
 
Ribosomal frameshifting does not necessarily lead to the synthesis of functional 
products. When frameshifting occurs due to limitations of translation accuracy it 
leads to the synthesis of aberrant products. Thus, it is expected that frameshift-prone 
sequences should be avoided in most coding regions. Indeed a strong evolutionary 
selection is observed that eliminates sequences that are strongly prone to 
frameshifting in protein-coding genes (Shah et al., 2002). Such selection is also 
observed for some (Gurvich et al., 2003), but not all, weak frameshift-prone 
sequences (Jacobs et al., 2007, Sharma et al., 2014, Belew et al., 2008), and in either 
case they are frequently found among coding regions (Gurvich et al., 2003, Jacobs et 
al., 2007, Sharma et al., 2014, Belew et al., 2008). These occurrence patterns suggest 
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that abortive frameshifting at low frequency might also be beneficial for regulatory 
purposes under certain conditions. Such frameshifting has been shown to reduce the 
stability of those mRNAs where it occurs, thus downregulating expression of the 
encoded proteins (Belew et al., 2011). Moreover, a human gene, the HIV-1 co-
repressor CCR5, where such abortive frameshifting is regulated by miRNAs has 
been reported recently (Belew et al., 2014).     
 
1.4.3 Frameshifting sites, stimulators and attenuators.  
 
Perhaps one of the reasons why ribosomal frameshifting is widespread as a local 
decoding alteration is its responsiveness to the sequence elements within an mRNA. 
Most cases of ribosomal frameshifting require a combination of a frameshifting site 
(a specific mRNA sequence where frameshifting takes place) and a stimulatory 
element (a sequence in the same mRNA that increases the efficiency of 
frameshifting).  
With the exception of those cases described later, frameshifting sites alone 
are insufficient to trigger efficient frameshifting and require one or more stimulatory 
elements embedded in mRNA. Stimulatory elements can be of diverse types. In 
bacteria, mRNA complementary to ribosomal RNA may facilitate frameshifting in 
the +1 as well as in -1 directions (Weiss et al., 1988, Larsen et al., 1994, Prere et al., 
2011). Nascent peptides are also known to modulate ribosomal frameshifting 
(Gurvich et al., 2011, Yordanova et al., 2015). The largest class of stimulators are 
RNA secondary structures: stem-loops (Kim et al., 2014, Yu et al., 2011, Mazauric 
et al., 2008), simple (Brierley et al., 1989) and relatively complex RNA pseudoknots 
containing extra stems (Baranov et al., 2005, Plant et al., 2005, Su et al., 2005) or 
triple helices (Chou and Chang, 2010, Chen et al., 2009), kissing loops (Herold and 
Siddell, 1993), G-quadruplexes (Endoh and Sugimoto, 2013, Yu et al., 2014) or 
long-range interactions (Tajima et al., 2011, Barry and Miller, 2002) (see refs 
(Giedroc and Cornish, 2009, Chung et al., 2010, Brierley et al., 2008, Atkins and 
Gesteland, 2010) for reviews). mRNA interacts with various cellular components, 
and these interactions may alter the stimulatory properties of particular structures or 
sequences. Both protein molecules (Li et al., 2014) and nucleic acid molecules 
(Howard et al., 2004, Olsthoorn et al., 2004, Belew et al., 2014) have been shown to 
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modulate frameshifting in trans. The dependence of frameshifting on stimulatory 
elements, as well as the responsiveness to cellular conditions, provides translation 
with a powerful regulatory mechanism. Fine regulation can be achieved through the 
balance between positive and negative regulators; therefore it is reasonable, though 
nonetheless surprising, that in addition to stimulators, there are also attenuators of 
frameshifting (Kurian et al., 2011, Su et al., 2005, Plant et al., 2010). The 
remarkable way in which such an attenuator operates was described in the S. 
cerevisiae OAZ1 antizyme gene, where it has been proposed that in the presence of 
high polyamine levels a nascent peptide in the exit tunnel promotes ribosome 
stalling at the end of antizyme ORF2. It was proposed that the resultant pile up of 
ribosomes promotes termination of ribosomes at the ORF1 stop codon, thus 
reducing the frameshifting efficiency (Kurian et al., 2011). 
 
1.4.4 Frameshifting at triplet repeats.  
 
The frameshifting observed during translation of certain triplet repeats (Stochmanski 
et al., 2012, Wills and Atkins, 2006, Toulouse et al., 2005, Girstmair et al., 2013) 
can be described as a combination of frameshifting site and its stimulator. In this 
case it is difficult to clearly distinguish what is the stimulator and what is the 
frameshifting site because frameshifting can take place at more than one location in 
the sequence, which also serves as a stimulator. Decoding a long sequence of 
consecutive codons corresponding to the same tRNA could lead to depletion of the 
charged tRNA in the vicinity of the ribosome making the frameshifting on such 
repeats sensitive to tRNA concentrations (Girstmair et al., 2013). This is consistent 
with a frameshifting role as a sensor of cellular conditions.  
 
1.4.5 Universal frameshifting.  
 
In some circumstances, stimulators are not needed for efficient frameshifting. In S. 
cerevisiae, up to 40% efficient +1 frameshifting can occur at C.UU_A.GG_C 
(underscores denote codon boundaries in the initial reading frame and dots denote 
codon boundaries in the shifted reading frame) (Belcourt and Farabaugh, 1990). The 
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high efficiency of frameshifting can be explained by a simple kinetic model: upon 
tRNA slippage from CUU to UUA at the P-site, translation could quickly continue 
in the new frame due to a high concentration of tRNA cognate for the +1 frame 
GGC, while translation in the original frame is slowed due to the scarcity of tRNA 
cognate to zero frame AGG (Baranov et al., 2004). Frameshifting at C.UU_A.GG_C 
was initially found to be used in transposon Ty1 (Clare et al., 1988) and later was 
also found to be required for synthesis of ABP140 (Asakura et al., 1998). A few 
codons other than CUU were found to promote unusually efficient frameshifting 
when in the P-site (Vimaladithan and Farabaugh, 1994). For all these codons tRNAs 
with optimal codon–anticodon base pairing are missing in S. cerevisiae and there is 
evidence that frameshifting is strongly promoted by incorporation of near-cognate 
isoacceptor tRNAs at corresponding codons (Sundararajan et al., 1999).     
Therefore +1 ribosomal frameshifting at these heptameric high-efficiency 
frameshift sequences is a specific feature of S. cerevisiae and could be regarded as a 
feature of its genetic code. This feature affects the evolution of all genes in the 
genome because occurrence of strong frameshift-prone heptameric sequences would 
be highly detrimental for accurate protein synthesis of the genes that do not require 
frameshifting. As a result, these frameshift-prone heptamer sequences are the rarest 
heptamers in coding regions of S. cerevisiae (Shah et al., 2002).  
 Another case for frameshifting as universal feature of the genetic code has 
been proposed for vertebrate mitochondria where there are no tRNAs that recognize 
AGA and AGG codons. These were believed to be stop codons in the genetic code 
of vertebrate mitochondria. Temperley et al (Temperley et al., 2010) suggested that 
AGG and AGA codons are not recognized by termination factors, but instead 
promote -1 frameshifting at N_NN.U_AG.G and N_NN.U_AG.A (where N is any 
nucleotide). This places the A-site of the ribosome at the overlapping UAG stop 
codons. If this is true, the vertebrate mitochondrial genome could be described as 
non-triplet, with AGG and AGA codons as signals for -1 frameshifting rather than 
amino acid or stops. However, evidence was also provided that AGG and AGA may 
be recognized as stop codons by mitochondrial release factors (Young et al., 2010).  
More recently the frameshifting based model was challenged by a study 
which suggested that the nascent peptide chain is released from the stalled ribosome 
with the aid of ICT1, a general rescue factor of stalled ribosomes in mammalian 
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mitochondria (Akabane et al., 2014). Irrespective of whether Temperley’s elegant 
hypothesis is right, it provides an intriguing scenario for the existence of genetic 
codes with non-triplet features.  
 
1.4.6 Pervasive frameshifting.  
 
Normally ribosomal frameshifting is very infrequent. This is even true in organisms 
with universally strong frameshifting patterns such as C.UU_A.GG_C in S. 
cerevisiae because despite their high frameshifting efficiency these heptamers occur 
only rarely in the genome. By contrast, ribosomal frameshifting in Euplotes ciliates 
is widespread. Analysis of the sequence and expression of several Euplotes genes 
revealed the frequent presence of frameshifting strongly associated with 
A.AA_U.AA_N and its minor variant A.AA_U.AG_N. It has been estimated that 
frameshifting is likely to occur in the decoding of 10% of all Euplotes genes 
(Klobutcher and Farabaugh, 2002). As described above the Euplotes genetic code is 
a variant one with the UGA stop codon reassigned to cysteine. The current 
explanation for the high frequency of frameshifting in Euplotes is that the alteration 
of the mRNA-recognition properties of the Euplotes release factors required for the 
reassignment also weakened recognition of UAG and UAA codons. Inefficient 
termination at these codons could favour an alternative event, ribosomal 
frameshifting at AAA codons (Vallabhaneni et al., 2009). It remains unclear, 
however, whether all occurrences of A.AA_U.AA_N and A.AA_U.AG_N 
sequences lead to frameshifting in Euplotes and with what efficiency. It is also 
unknown whether these sequences are the only ones that promote frameshifting in 
Euplotes. 
 
1.5 The multitude of stop codon meanings. 
 
Stop codons are clearly the most versatile codons. Nearly all codon reassignments in 
non-mitochondrial genomes involve stop codons. Stop codons are frequently found 
in +1 frameshifting sites, a stop codon is required for translational bypassing in T4 
bacteriophage gene 60 and all known codon redefinitions involve stop codons (with 
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the conspicuous exception of selenocysteine insertion in Euplotes species (Turanov 
et al., 2009). See Fig. 1.4 for various examples of altered stop codon meanings.  
 What makes stop codons so flexible? First, stop codons are the rarest codons 
in coding sequences. Genes that do not use alternative decoding in their expression 
need only a single stop codon. As a result stop codons are less frequent than most 
sense codons by an order of a magnitude. Furthermore, stop codon usage is often 
skewed (Korkmaz et al., 2014) and as a result a particular stop codon can be 
exceptionally rare.  Thus a codon reassignment of a stop codon may affect only a 
few codons in the genome. In addition alteration of stop codon meaning is unlikely 
to dramatically change the properties of protein products. Stop codons are as 
frequent outside of coding regions as any other triplet, thus if a stop codon is 
decoded as a sense codon a corresponding protein will be extended only by a few 
amino acids, as another stop codon is likely to be found downstream.  
 The other important difference in decoding of stop codons is that they are 
recognized by release factor proteins rather than by RNA molecules. In fact, the 
reason why they are recognized by proteins could also be due to their comparatively 
high evolvability. Release factors in eukaryotes and archaea do not share a common 
ancestor with those in bacteria, suggesting that the protein-based termination of 
translation is a relatively recent invention and the last universal common ancestor 
(LUCA) used a different mechanism (perhaps RNA based) for termination of 
protein synthesis. Because termination of translation relies on protein factors, the 
mechanism of mRNA recognition is substantially different. While release factors 
still recognize stop codons as triplets, they interact with larger region of mRNA and 
thus efficiency and accuracy of termination is more sensitive to the sequence 
downstream than in the case of strictly triplet tRNA decoding. As a result, the 
strength of stop codons varies substantially depending on the sequence downstream 
of stop codons (Pavlov et al., 1998, Bonetti et al., 1995, Namy et al., 2001). 
Particularly weak codons are often used for stop codon readthrough or ribosomal 
frameshifting because the weak termination provides latitude for a competing 
process. 
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Figure 1.4: The multitude of stop codon meanings. Stop codons are shown as red 
circles, and the types of altered meanings are shown in green (for amino acid 
incorporations or translational bypassing) and grey (for frameshifting).  
 34 
 
 
1.6   Unusual disruptions of triplet continuity 
 
1.6.1 Translational bypassing.  
 
What happens during translation of bacteriophage T4 gene 60 could be described as 
a +50 frameshifting, as two codons encoding a pair of adjacent amino acids in its 
protein product are separated by a 50 nucleotide-long non-coding gap (Fig. 1.3). 
Ribosomes suspend translation at a specific glycine codon and resume translating at 
another glycine codon 50 nucleotides downstream. This case was discovered in 1988 
(Huang et al., 1988) (Fig. 1.1b), and until recently was the only known example of 
translational bypassing (also known as ribosomal hopping). The intensive research 
of the molecular mechanism of translational bypassing revealed a complex nexus of 
stimulatory elements within the mRNA that includes an enigmatic requirement for a 
stop codon at the start of the non-coding gap to be dynamically folded into an RNA 
secondary structure and a role for the specific sequence of the nascent peptide (Wills 
et al., 2008, Herr et al., 2000a, Herr et al., 2000b, Weiss et al., 1990, Samatova et al., 
2014).  
The uniqueness of this case, combined with the complexity of the sequence 
elements involved, seeded doubt about the existence of other examples of 
translational bypassing. However, recently likely candidates have been identified in 
Streptomyces phages (Smith et al., 2013), with most striking examples of 
translational bypassing being found in mitochondria of the yeast Magnusiomyces 
capitatus (Lang et al., 2014). The transcriptome of these mitochondria contains 
dozens of untranslated regions of various sizes which were termed byps to indicate 
their relationship to the translational bypassing in decoding bacteriophage T4 gene 
60. The exact sequences of byps vary, although they share certain features of 
primary as well as of secondary RNA structure (Lang et al., 2014). Bypassing at M. 
capitatus byps does not occur when the corresponding sequences are expressed in E. 
coli and hence is likely to require specific features of the M. capitatus translational 
machinery (Lang et al., 2014). Byps are probably mobile genetic elements and it is 
likely that the M. capitatus translational machinery evolved the ability to avoid them 
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during translation so that insertion of byps into a coding region would not be 
deleterious (Lang et al., 2014). 
 
1.6.2 Trans-translation 
 
The term trans-translation describes the translation of two messenger RNAs into a 
single polypeptide (Fig. 1.3). Most bacteria use trans-translation to deal with 
truncated mRNAs that lack stop codons. Ribosomes that stall at the end of truncated 
mRNAs are recognized by elongation factor EF-Tu in a complex with a molecule 
called tmRNA (for transfer and messenger RNA). tmRNA functions as tRNA, as it 
is charged with an amino acid which is then transferred onto the nascent peptide in 
the stalled ribosome. It also functions as mRNA, as it contains a short ORF that is 
decoded after its incorporation into the ribosome. The tmRNA ORF encodes a signal 
for protein degradation, thus allowing the cell to destroy potentially toxic products 
of truncated mRNAs and also to recycle the stalled ribosomes (see refs (Keiler and 
Ramadoss, 2011, Himeno et al., 2014) for reviews and the database of tmRNA 
sequences (Hudson and Williams, 2014)). This system is remarkably conserved in 
the bacterial world and has been lost only in a few highly reduced genomes (Hudson 
et al., 2014). Therefore, trans-translation may be described as a global feature of 
genetic decoding in organisms with tmRNA, since it universally adds a particular 
peptide sequence to any protein product of translated ORF that lacks a stop codon.  
 
1.6.3 StopGo.  
 
StopGo (also known as Stop-Carry on) allows two separate peptides to be produced 
from the same ORF (Fig. 1.3). It was first characterized in an aphthovirus, foot-and-
mouth disease virus (FMDV), where it occurs during decoding of a polyprotein-
encoding mRNA (Donnelly et al., 2001a, Donnelly et al., 2001b). In this case, 
ribosomes decode codons according to the standard genetic code and in a triplet 
manner. However, the continuity of decoding is disrupted by a break at a specific 
location. The function of this event is parallel to the proteolytic cleavage at specific 
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sites in other viral polyproteins, but with StopGo there is no requirement for a 
protease. 
 
1.7 Transcriptional recoding and alternative initiation of 
translation.  
 
The focus of this Review is on alternative decoding events that take place during 
translation elongation or termination. However, there are many pre-translational 
events (occurring co-transcriptionally or post-transcriptionally) that alter genetic 
decoding in similar ways. C-to-U and A-to-I RNA editing may change the meaning 
of a codon template in DNA (see refs (Maas, 2012, Kiran et al., 2011, Mallela and 
Nishikura, 2012) for reviews). Pseudouridinilization of mRNA (Carlile et al., 2014) 
affects decoding in a complex way and could result in readthrough of stop codons 
containing a pseudouridine (Karijolich and Yu, 2011).  
Programmed transcriptional realignment (PTR) affects decoding similarly to 
programmed ribosomal frameshifting (PRF) and these two mechanisms are easily 
interchangeable (Fig. 1.5a).  dnaX was the first example where the use of PRF and 
PTR in orthologous genes was revealed (Larsen et al., 2000).  
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Figure 1.5 Schematic representation of the parallel between alternative 
initiation and stop codon readthrough (a) and between transcriptional slippage and 
translational frameshifting (b). 
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Alternative initiation of translation is analogous to stop codon readthrough in the 
sense that both generate multiple proteoforms, but with variant N-termini in case of 
alternative initiation and C-termini in case of stop codon readthrough (Fig. 1.5b). 
Alternative translational initiation is a widespread phenomenon with important 
implications for gene expression. Many human genes contain evolutionarily 
conserved protein-coding non-AUG initiated extensions in their 5’ leaders (Ivanov 
et al., 2011) and repeat-associated non-AUG initiation is implicated in human 
neurodegenerative disorders (Wojciechowska et al., 2014, Kearse and Todd, 2014, 
Cleary and Ranum, 2013). 
 
1.8   Conclusions and future perspectives 
 
In this Review we focused on alternative genetic decoding occurring during 
translation elongation. Parallel mechanisms can also be employed during 
transcription or translation initiation, and we have only briefly discussed them. 
However, the remarkable flexibility of genetic decoding is evident from the 
examples discussed. Genetic decoding can be altered globally as a result of 
modifications to the translation machinery or locally in specific mRNAs that evolve 
special sequence elements to alter their decoding and to regulate their own 
translation. A crucial aspect of alternative genetic decoding is relevance to synthetic 
biologists who can take advantage of genetic decoding plasticity to construct 
regulatory and sensory genetic modules. Synthetic organisms with genetic codes not 
found in nature are also being made. 
It is unlikely that we are aware of all the ways that genetic decoding can be 
altered in nature, and future discoveries will undoubtedly continue to surprise and 
inspire us. Comparative sequence analysis may help us to reveal alternatively 
decoded genes that are currently hidden from our sight because they do not fit 
standard gene models used for identification of protein coding genes. However, it is 
unlikely to reveal the entire spectrum of recoded genes. The power of comparative 
sequence analysis is limited by the range of species. With higher eukaryotes the 
problem also lies in deconvolution of signatures of evolution in protein-coding 
regions in the presence of alternative splicing.  Complementary experimental 
techniques for genome-wide analysis of protein synthesis such as ribosome profiling 
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have emerged. Although, for many recoded genes it may be difficult to find 
conditions in which they are expressed, combinations of genome-wide phylogenetic 
and biochemical approaches are already accelerating the discovery of new cases. 
The growing repertoire of alternative genetic decoding events will ultimately 
challenge the way we annotate genes and genomes and how we represent protein 
coding information in sequence databases. 
 
1.9 Glossary 
 
A-site 
The ribosomal site that accommodates either the aminoacyl-tRNA carrying the next 
amino acid to be added to the growing polypeptide chain or a release factor. 
Abortive PRF 
Programmed ribosomal frameshifting (PRF) that results in synthesis of 
dysfunctional protein products or in downregulation of functional protein synthesis.  
Ambiguous intermediate 
An evolutionary state in the history of an organism evolving a variant genetic code 
in which a particular codon has two standard meanings.  
Byps 
Noncoding gaps in mRNAs of mitochondria (in M. capitatus and related species) 
that escape decoding through frequent translational bypassing. 
 
Codon capture 
An evolutionary event in which a codon that disappears from a genome, reappears in 
its descendant and acquires a different standard meaning, thus leading to a variant 
genetic code. 
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Codon redefinition 
A local change of a codon meaning which is dependent on the context in which it 
occurs. 
Fixed codon reassignment 
A complete unconditional change of the standard meaning of a codon. 
Frameshifting site 
(Also known as frameshift site or shift site). A sequence where ribosomal 
frameshifting takes place. It includes codons in the A- and P- sites of the ribosomes 
just before and after the frameshifting.  It is useful to describe the sequence of the 
frameshifting site denoting codons in the original and new frames, e.g. 
C.UU_A.GG_C. Such representation unambiguously reflects the direction (minus or 
plus) as well as the mechanism of frameshifting (+1, +2, etc)  
Genetic code 
A correspondence between 64 triplet combinations of four nucleotides and their 
standard amino acid or stop meanings.  
P-site  
The ribosomal site which accommodates the peptidyl-tRNA carrying the growing 
polypeptide chain. 
Productive PRF 
A type of programmed ribosomal frameshifting (PRF) that is required for the 
production of a functional protein product.  
Programmed ribosomal frameshifting (PRF) 
Ribosomal frameshifting that is programmed (by a sequence context) to occur at a 
specific mRNA location.    
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Proteinogenic amino acids 
Amino acids that are incorporated into proteins co-translationally. 
Proteoforms 
Groups of sequence-related proteins arising from the same mRNA. 
Purifying evolutionary selection  
The removal of disadvantageous traits. In the case of protein-coding sequences it 
results in a higher rate of synonymous substitutions relative to non-synonymous 
substitutions.    
Recoding 
A process of context- or condition-specific alteration of the genetic decoding.  
Regulated codon reassignment 
A conditional change of the standard meaning of a codon. 
Ribosomal frameshifting 
A process in which a ribosome changes its reading frame. 
SECIS element  
(Also known as Sec insertion sequence). An mRNA secondary structure that 
functions as a stimulatory element for selenocysteine incorporation. 
Standard meaning  
The way the translational machinery interprets a codon (coding for a proteinogenic 
amino acid or a signal for translation termination) unless it occurs in a special 
context. 
Stimulatory element  
An mRNA element that is required for the efficient local alteration of genetic 
decoding. 
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StopGo 
(Also known as Stop-Carry on). A process in which production of a polypeptide 
chain is interrupted at a specific place while triplet mRNA decoding continues. This 
results in production of two protein products from a single open reading frame. 
Stop codon readthrough 
A redefinition of a stop codon to a sense codon irrespective of functional 
implications of the identity of incorporated amino acid. 
Isoacceptors 
Different tRNA species carrying the same amino acids but with different anticodon 
sequences 
Trans-translation  
A process in which a single protein is translated from two mRNA molecules as 
templates.   
Translational bypassing 
A process in which ribosomes skip three or more nucleotides without decoding.  
Variant genetic codes 
Genetic codes that differ from the standard genetic code shown in Fig. 1.1a.  
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Chapter 2  
Regulatory nascent peptides.  
 
2.1 The ribosomal exit tunnel  
 
The formation of the peptide bond during protein synthesis  occurs in a cleft of the 
large subunit of the ribosome near the interface between the two subunits , at a site 
referred to as the peptidyl transferase centre (PTC) (Simonovic and Steitz, 2009). 
Following the peptide bond formation, the growing peptide chain leaves the 
ribosome through the exit tunnel in the large ribosomal subunit (Bischoff et al., 
2014).  
The tunnel is about 100 Å long and 20 Å wide and accommodates a 30 to 40 
amino acid long poly-peptide chain in its extended conformation. The tunnel can be 
separated into several areas – the upper tunnel is the closest to PTC; the constriction 
area is the narrowest part of the tunnel where residues of the ribosomal proteins L4 
and L22 (naming as in bacteria; in eukaryotes the protein L17 is the homolog of the 
bacterial L22) protrude; the lower tunnel, and the vestibule next to the tunnel exit. 
Owing to its confined volume, the tunnel cannot accommodate bulk domains with 
tertiary structure. However, alpha-helix formation was observed in the lower tunnel 
(Wilson and Beckmann, 2011) and Nilsson et al., have demonstrated that small 
domains such as ADR1a domain can fold within the vestibule of the exit tunnel 
(Nilsson et al., 2015). The authors have suggested that similarly to chaperones, that 
bind to the emerging nascent polypeptide chain and facilitate its proper folding, the 
interaction of the nascent polypeptide with exit tunnel components might be 
promoting the folding of some small domains (Nilsson et al., 2015). 
The ribosomal tunnel is predominantly composed of large ribosomal subunit 
rRNA. Amino acid residues of large ribosomal subunit proteins also participate in 
the shaping of the tunnel, such as residues of the proteins L4 and L22 (L17 in 
eukaryotes) which form the tunnel constriction. The dominant occurrence of rRNA 
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results in an overall negative environment of the tunnel (Lu et al., 2007, Lu and 
Deutsch, 2008). The negative potential is the least in the area just next to the PTC 
and the greatest in the area of the constriction (Lu et al., 2007). Consistent with the 
negative charge of the tunnel, a stretch of positively charged amino acids while in 
the tunnel has been shown to cause the translating ribosomes to pause (Lu et al., 
2007). The negative potential however is not static – as it moves through the tunnel, 
the nascent chain can alter the tunnel environment locally (Lu et al., 2007). This is 
accomplished in part by the charged residues of the nascent chain. In addition, the 
bulkiness of the amino acids side chains and the local conformations of the 
polypeptide chain within the tunnel determine the access of water and ions that 
shield the tunnel charges.   
Originally the tunnel was considered to be immune to interaction with the 
growing peptide chain. However further discoveries have shown that the tunnel is 
not simply a passive conduit that contains the nascent polypeptide chain until it 
emerges at the surface of the large subunit. The interactions of the nascent 
polypeptide within the tunnel of the ribosome may pause or even stall the ribosome. 
A class of stalling nascent peptides employ this feature for regulatory purposes. 
Such peptide sequences can stall the ribosome during translation elongation or 
termination. In bacteria, several cases are known where stalling at regulatory leader 
peptides promotes the reorganisation of RNA secondary structure, resulting in 
exposure of the Shine-Dalgarno sequence of the downstream cistron, upregulating 
its translation (Murakami et al., 2004, Gong and Yanofsky, 2003). Stalling at uORFs 
in eukaryotes reduces the number of ribosomes reaching the main ORF start codon 
and thus inhibiting translation of the main ORF. The stalling may be achieved with 
polypeptides that are shorter than the length of the ribosome tunnel and is often 
dependent on the presence of small molecules like antibiotics or amino acids.   
Several stalling peptides are well described, surprisingly however they 
display very low sequence similarity. Despite the lack of consensus sequence, a 
prolyl-tRNA is often found in the A-site. Proline is an imino acid because the 
nitrogen of the amino group involved in peptide bond formation is in addition bound 
to the carbonyl of the side chain. This results in a reduced reactivity of the amino 
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group and accounts for the slow kinetics of peptide bond formation with prolyl-
tRNA in the A-site (Pavlov et al., 2009). It has been suggested that the slow kinetics 
of peptide bond formation with proline as a substrate may provide a time interval for 
the formation of specific contacts of the nascent chain within the tunnel, resulting in 
ribosome stalling. In bacteria, where it has been shown that runs of prolines cause 
ribosome stalling, the translation factor EFP was found to alleviate the stall at 
polyproline stretches. A recent study demonstrated that the major determinant of the 
slow kinetics of the reaction is the suboptimal orientation of Pro-tRNA in the PTC. 
It was established that EFP facilitates the peptidyl transferase reaction by promoting 
catalytically productive orientation of the Pro-tRNA in the PTC (Doerfel et al., 
2015).  
Regulatory nascent peptides, alone or in concert with other molecules (e.g. 
antibiotics or small metabolites) establish contacts with tunnel components. These 
interactions are transformed into instructions for the ribosome to alter its behaviour 
in response to environmental cues. Mechanistically this is achieved by relaying 
allosteric changes, initiated by the interactions of the nascent peptide with tunnel 
components, to the residues in the PTC resultant in an impaired PTC function. 
 The growing polypeptide chain is attached through an ester bond to the 3′ 
hydroxyl of the 3’ terminal ribose of the P-site tRNA. In the absence of an A-site 
substrate, residues in the PTC in particular U2585 (see Table 2.1) shield the peptidyl 
ester linkage, protecting it from hydrolysis by water molecules. Upon binding of an 
A-site substrate (aminoacyl-tRNA or a release factor) a rearrangement of the 
residues in the PTC is observed (Voorhees et al., 2009) making the peptidyl ester 
available for nucleophilic attack. The precise positioning of the peptidyl ester 
linkage in the P-site and the nucleophilic amino group of the aminoacyl-tRNA in the 
A-site is crucial for peptide bond formation and it is maintained by the specific 
orientation of the 23S residues in the PTC. Similarly, the correct positioning of the 
release factor and in particular that of its GGQ domain, is crucial for efficient 
termination to occur, and it is mediated by rRNA residues (Brown et al., 2015). The 
dynamic orientation of PTC residues is therefore reflective of the ribosome 
functional state. This is why even the slightest change in the orientation of the PTC 
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residues can be inhibitory on the peptide bond formation or hydrolysis (Wilson and 
Beckmann, 2011).    
There are two main areas where the nascent peptide chain communicates 
with tunnel components; the constriction area in the ribosome tunnel and the area of 
the upper tunnel close to the PTC where rRNA residues can directly transmit the 
signal to the PTC. The rRNA residues of the PTC are the final receivers of the signal 
initiated by the contact between the nascent polypeptide chain with tunnel 
components. Most rRNA residues in the PTC are universally conserved and 
mutating some of them was shown to be lethal. Naturally occurring substitutions 
account for functional differences. Such is the case with adenine at position 2058 
(A2058) in bacteria which has been naturally substituted for guanosine in eukaryotes 
and archaea. This is considered to be a major factor contributing to erythromycin 
resistance exhibited by eukaryotes and archaea and not by bacteria (Dunkle et al., 
2010). However, some bacteria can temporarily modify A2058 in response to 
erythromycin and other similar antibiotics. The inducible methyltransferases add a 
methyl group to A2058 which alteration is considered as the main factor for the 
acquired antibiotic resistance of these bacteria. 
Owing to their importance, mutating many of the rRNA residues in the PTC 
is lethal. Hence, direct testing of the effects of specific residues on translation was 
not possible till now. Recent studies described the creation of the first fully 
orthogonal ribosome–messenger RNA system (Orelle et al., 2015, Fried et al., 
2015). It allows for testing the effect of various alterations of the ribosome, 
including mutations of the PTC residues known to be otherwise lethal. Indeed using 
this system generated the first direct evidence for the role of a specific 23S rRNA 
nucleotide, namely A2451, in SecM programmed ribosome stalling (Orelle et al., 
2015).     
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A2058 -part of the binding site of macrolide antibiotics such as 
erythromycin 
 
A2059 -part of the binding site of macrolide antibiotics such as 
erythromycin 
 
 
U2585 
 
-catalysis of peptide bond formation  
-The second most flexible residue in the PTC 
-conformational state reflects the functional state of the 
ribosome  
(Schmeing et al., 
2005), 
(Voorhees et al., 
2009) 
A2602 
 
-The most flexible residue in the PTC 
-conformational state reflects the functional state of the 
ribosome  
-crucial for the proper peptidyl hydrolysis activity 
-mutations strongly reduce SecM and ErmCL-mediated 
stalling but have no effect on TnaC- stalling 
(Vazquez-Laslop 
et al., 2010) 
 
 (Wilson and 
Beckmann, 
2011) 
A2053 -a crucial component of the tunnel wall, that together with the 
nearby A2062 transmit signal from the tunnel to the PTC   
-mutations strongly reduce SecM and ErmCL-mediated 
stalling but have no effect on TnaC- stalling 
(Vazquez-Laslop 
et al., 2010). 
 
(Wilson and 
Beckmann, 
2011) 
Residues 
L4 and 
L22 
-binding site for some antibiotics.  
-mutations in these residues alleviate the effect of nascent 
peptide mediated stalling   
(Tu et al., 2005) 
 
Table 2.1: Role of some prominent components of the tunnel wall and the PTC. 
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2.2 Regulatory peptides in Bacteria 
 
 
2.2.1 SecM 
 
In bacteria the export of proteins through the Sec translocon is powered by the motor 
protein SecA, an ATPase (Denks et al., 2014). SecA expression is regulated in 
accordance with the secretion needs of the cell (Oliver et al., 1998). Monitoring the 
secretory status of the cell relies on a regulatory mechanism that takes place during 
the translation of SecM (secretion monitor) protein (Nakatogawa and Ito, 2001). In 
its N terminus the protein SecM carries a secretory signal which guides its export 
through the membrane into the periplasmic space where SecM is quickly degraded. 
The 170 codon long SecM ORF is located upstream of SecA in the same operon. 
The amino acid sequence starting at Phenylalanine (Phe) at position 150 and ending 
at Proline (Pro) at position 166 acts from within the ribosome exit tunnel to stall the 
translating ribosome with SecM1-165-tRNAGly in the P-site and Prolyl166- tRNAPro 
in the A-site (Nakatogawa and Ito, 2002). As the arrest sequence is close to the C 
terminus of the protein, at the moment of stalling, most of the protein has already 
emerged at the surface of the ribosome. This newly synthesised polypeptide chain is 
bound by the components of the translocation machinery. The ribosome stalling is 
released upon the ‘pulling’ of the protein chain exerted by the co-translationally 
occurring translocation process (Butkus et al., 2003). Ribosome stalling at the SecM 
arrest sequence, allows for rearrangement of an mRNA secondary structure that 
exposes the Shine-Dalgarno sequence of the downstream SecA. In conditions where 
SecM is efficiently translocated through the membrane, the stalling at the arrest 
peptide is transient. Therefore normally, SecA is constitutively expressed at low 
levels (Murakami et al., 2004). In case of secretion deficiency the duration of the 
stall is prolonged and this results in an increase in SecA expression (Murakami et al., 
2004) (Fig.2.1). 
 Mutational analysis has identified 9 key residues in the SecM arrest peptide 
sequence from E. coli (shown in bold) 150 FSTPVWISQAQGIRAGP166. Mutating 
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these residues reduced or completely alleviated the stalling (Nakatogawa and Ito, 
2002). However, a more extensive analysis has revealed an unexpected flexibility 
regarding the identity of residues in the arrest peptide. Only Arg163 was 
indispensable (Yap and Bernstein, 2009). Therefore, it was proposed that the role of 
the non-essential residues was to promote the formation of specific SecM nascent 
peptide conformation in the tunnel.  Perhaps different combinations of amino acid 
residues can fold the nascent peptide in the tunnel in a way to bring the essential 
Arg163 residue in contact with specific tunnel components. Such interactions could 
initiate allosteric rearrangements that are relayed to the PTC and result in interfering 
with peptide bond formation to promote stalling. The authors have suggested that the 
presence of essential and context-specific residues might be a general feature of 
arrest peptides that could explain their sequence diversity (Yap and Bernstein, 2009).  
Several mutations in tunnel components that disrupt stalling at SecM were 
identified. One such was a mutation of the 23S rRNA nucleotide A2058 which faces 
the interior in the constriction area of the tunnel. Mutation at that position alleviated 
the stalling (Nakatogawa and Ito, 2002). Similarly the stalling was alleviated by a 
nucleotide insertion within the A749–A753 region, also located in the constriction 
area however at the opposite tunnel wall. Mutations of several residues of the large 
ribosome protein L22 that protrudes into the constriction area were also among those 
that alleviated SecM mediated stalling. The mutation of A2053, which was identified 
as an important component of the relay system that connects the tunnel and the PTC, 
also abolishes stalling with ErmCL as well as with SecM (Vazquez-Laslop et al., 
2010). It is likely that A2053 acts together with the closely positioned A2062. A2053 
and A2062 are proximal to PTC and their interaction with the indispensable Arg 
residue has been revealed by CryoEM (Gumbart et al., 2012)  
 The translation pause at the SecM arrest sequence is released by the pulling 
force exerted by the association with the translocon. It was demonstrated that a 
similar pulling force could also be generated by the co-translational folding of the 
newly produced polypeptide chain at the surface of the ribosome (Goldman et al., 
2015). When sequence encoding protein domain with a known folding potential was 
connected by a linker upstream to the arrest peptide encoding sequence, the force 
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generated from the folding of the domain at the ribosome surface could rescue the 
stalled ribosome and increase the translation rate. This opens the possibility that 
such coordination between co-translational folding and elongation rate might be a 
more general feature of the translation process. For example, pausing at certain 
sequences during elongation can provide the means for monitoring the folding status 
of the polypeptide molecule that already has emerged from the exit tunnel. The 
pulling force generated by proper folding of the chain would rescue the stalled 
ribosome and signal translation to continue. In case of a folding defect, the stalled 
ribosome could not be rescued and prolonged stalling may result in triggering 
different rescue mechanisms. 
 The binding of protein partners to the emerging chain could be another 
means for generating force to alleviate stalling and hence modulate the translation 
elongation rate (Goldman et al., 2015).  
 
 
 
 
 
 
 
 
Figure 2.1: Ribo-seq (red) coverage in a portion of the SecM transcript from three 
different studies. The light blue panel indicates the position of the peak 
corresponding to the site of nascent peptide mediated stalling during SecM 
translation elongation.  First row illustrates data generated by (Liu et al., 2013), 
second row (Oh et al., 2011), and third row (Li et al., 2012). The peak at the end of 
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SecM is not noticeable in the first row where data was obtained in the conditions of 
bacteriophage lambda infection. The image was obtained from GWIPS Viz. 
 
2.2.2 TnaC 
 
The TnaC gene in the E. coli tryptophanase operon encodes a regulatory leader 
peptide that ‘senses’ tryptophan (Trp) levels (Gong and Yanofsky, 2002, Gong et al., 
2001). It regulates the expression of 2 structural genes further downstream in the 
operon; TnaA and TnaB which encode enzymes for Trp degradation 
(tryptophanase), and export (permease) respectively (Deeley and Yanofsky, 1981, 
Edwards and Yudkin, 1982).   
 TnaC is an example of a mechanistic coupling of transcription and 
translation (Ito and Chiba, 2013, Gong and Yanofsky, 2003). The translation of 
TnaC regulates the transcription of TnaAB in the Tna operon. Observe that this is 
possible in bacteria because their transcription and translation are not separated 
either spatially or temporally. The RNA polymerase transcribing the Tna operon 
stalls at the beginning of the TnaA gene. In order to proceed, it needs a ‘push’ from 
the ribosome translating TnaA. With high Trp the translating ribosomes stall at the 
end of TnaC, preventing the reformation of a secondary mRNA structure and in this 
way exposing the TnaA Shine-Dalgarno sequence. Ribosomes can now initiate 
translation of TnaA and catch up with the paused RNA polymerase. The latter can 
then proceed transcribing the TnaAB operon (Gong and Yanofsky, 2003). The 
stalling is seen with ribosome profiling data (Fig. 2.2). In low Trp levels, the 
ribosomes translating TnaC terminate at the stop codon and dissociate, allowing 
reformation of the mRNA structure that hides the Shine-Dalgarno sequence. In 
addition, when there is no a stalled ribosome to hinder its binding sites, the 
transcription termination factor Rho binds to the mRNA sequence between TnaC 
and TnaAB. Transcription termination then occurs prior to TnaAB transcription 
(Konan and Yanofsky, 2000, Gong and Yanofsky, 2003). 
 The ribosome translating TnaC stalls with peptidyl-tRNA
pro 
in the P-site and 
the UGA stop codon in the A-site (Gong et al., 2001). Extensive mutagenesis of the 
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24 amino acid long TnaC polypeptide has revealed the identity of critical residues as 
well as their spacing relating to the P-site. A recent CryoEM study has provided a 
detailed view of the nascent TnaC peptide within the exit tunnel (Bischoff et al., 
2014). The authors revealed that the nascent peptide acquires specific conformation 
which allows for the formation of two hydrophobic pockets, in each pocket a Trp 
molecule was found to be bound.  
 One of the Trp molecules binds between nucleotides A2058 and A2059 on 
one side of the tunnel and U2609 and A752 on the other (Bischoff et al., 2014). The 
nascent peptide interacts with L4 and L22 residues of the constriction area of the 
tunnel. In particular, the indispensable TnaC residues D16 and W12 were shown to 
interact with residues of L22. These and other interactions relay the signal to the 
PTC where residues U2585 and A2602 acquire conformations that hinder proper 
RF2 binding. This causes the observed ribosome stalling with the stop codon in the 
A site (Bischoff et al., 2014). Most of the rRNA nucleotides and the protein residues 
that were identified to interact with the nascent peptide chain, were also already 
established in mutational analysis as crucial participants required for the stalling 
effect in response to Trp (Cruz-Vera et al., 2007).  
 In the model derived with the CryoEM data, the TnaC nascent peptide forms 
a specific conformation within the exit tunnel accomplished via interactions between 
peptide residues with components of the tunnel. In this specific conformation two 
hydrophobic pockets form in the tunnel. When high levels of Trp are available two 
Trp molecules are accommodated in the hydrophobic pockets. The bound Trp 
molecules interact with specific 23S rRNA nucleotides as well as with TnaC 
residues further stabilising a particular nascent peptide conformation within the 
tunnel. This conformation triggers allosteric rearrangements resulting in the 
positioning of nucleotides from the PTC in such a way as to impair the proper 
binding of the release factor which results in ribosome stalling.   
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Figure 2.2: Ribo-seq (red) data coverage in the TnaC gene from the tryptophanase 
operon in E.coli. The light blue panel indicates the position of the peak 
corresponding to the site of TnaC mediated stalling. The peak to the left may 
represent the second stalled ribosome.   
 
2.2.3 ErmCL 
 
Inducible erythromycin resistance methylase (erm) genes in bacteria render 
resistance to macrolide antibiotics such as erythromycin. The expression of the erm 
genes is regulated at the level of translation by a programmed ribosome stalling 
event, mediated by arrest leader peptides.   
 Upon entering the ribosome exit tunnel, erythromycin establishes contacts 
with specific rRNA and protein components of the tunnel. The bound antibiotic 
limits the conformational freedom of the nascent chain in the tunnel stabilizing 
specific interactions of the latter with tunnel components. Together the interactions 
of the macrolide and the nascent chain with tunnel components result in PTC 
rearrangements that inhibit protein synthesis. These rearrangements can impede 
peptide bond formation between particular donor and acceptor amino acids, or 
preclude the accommodation of the A-site tRNA as in the case of ermCL (Ramu et 
al., 2011, Kannan et al., 2014). Interestingly erythromycin inhibits peptide bond 
formation of different combinations of donor and acceptor amino acids with 
different efficiency, thus its inhibition of protein synthesis is selective to a certain 
degree (Kannan et al., 2014).  
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 The inducible erm genes, such as ermC, have ‘learnt’ how to take advantage 
of the erythromycin inhibitory mechanism for induction of their own expression 
(and for providing bacteria expressing erm cassettes with resistance to antibiotics.) A 
regulatory region in the ermC 5’leader encodes a 19 amino acid long leader peptide, 
ErmCL. In the absence of antibiotic, the expression of the main cistron is inhibited 
due to the unavailability of its Shine-Dalgarno sequence and start codon, sequestered 
in an RNA secondary structure. Erythromycin causes the translating ribosome to 
stall at codon 9 of ErmCL, with the peptidyl-tRNAIle in the P site. Following this, 
RNA is refolded and the Shine-Dalgarno sequence becomes available for ribosome 
binding, which results in translation of the main cistron.    
 The ermC product is an rRNA methylase that adds methyl groups to N6 of 
the 23S rRNA residue A2058. This methylation is considered to be a major factor for 
the acquired resistance to erythromycin and similar antibiotics, due to the resultant 
conformational changes of the ribosome, interfering with the accommodation of the 
antibiotic. 
 Unlike other stalling peptides such as SecM or TnaC, ErmCL is only 9 amino 
acids long and thus it does not span the entire ribosome tunnel. The 9 residue long 
nascent chain has the sequence 1MGIFSIFVI9. Mutations have revealed that the 
residues of the C terminus, Ile6, Phe7, Val8, and Ile9 are crucial for the stalling to 
occur, while Met1, Gly2, Ile3, Phe4 and Ser5 at the N terminus are dispensable, 
although they are required for an optimal efficiency. These results are consistent 
with studies of other nascent peptides that have stalling effect in the presence of an 
antibiotic, for which only the sequence at the very C terminus is critical for the 
effect. It has been proposed that the antibiotic predisposes the ribosome for stalling 
even with very short arrest peptides in the tunnel (Sothiselvam et al., 2014).  
 The antibiotic bound in the exit tunnel narrows the tunnels space and 
promotes a nascent peptide conformation resultant in contacts with the tunnel and 
PTC. Specifically valine at position 8 interacts with U2506 and isoleucine at 
position 6 – with U2586, supporting previous studies where mutations of these 
amino acids to alanine have greatly reduced ribosome stalling (Johansson et al., 
2014, Vazquez-Laslop et al., 2008).  
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Mutations of the rRNA nucleotides A2053 and A2062 alleviated the 
erythromycin induced stalling at ermCL and identified these nucleotides as crucial 
component of the relay system sending signal to the PTC. A2053 is located at the 
tunnel wall close to PTC, and it has been demonstrated that changes of its 
conformation or methylation status directly induce changes in PTC. It has been 
identified as a crucial component of the tunnel wall, which together with the nearby 
A2062 transmit signal from the tunnel to the PTC (Vazquez-Laslop et al., 2010).   
 Eventually the interactions within the tunnel result in conformational change 
in A2585 in the PTC. As discussed above, U2585 is located in the PTC active site 
and is critically involved in the catalysis of peptide bond formation (Schmeing et al., 
2005, Voorhees et al., 2009). This prevents the correct positioning of the A site 
serine tRNA and hence the formation of a peptide bond is inhibited. 
 Mutations of specific ErmCL amino acid residues also alleviated the stall 
(Johansson et al., 2014).   
 
2.3 Regulatory peptides in Eukaryotes 
 
2.3.1 CGS1 
 
The CGS1 gene expressed in plants encodes cystathionine γ-synthase, an enzyme of 
the methionine biosynthetic pathway. Its expression is regulated with a feedback 
loop where a derivative of methionine, S-adenosyl-methionine (also known as SAM 
or AdoMet), has been shown to downregulate the translation of CGS1. 
 Toe-print analysis of in vitro translation reactions in wheat germ extract 
(WGE) has revealed that ribosomes transating CGS1 mRNA stall at the Ser codon at 
position 94 in the presence of AdoMet (Onouchi et al., 2005). Mutational analysis of 
the amino acid sequence preceding the stalling site has identified that a core peptide 
of 11 amino acids with the sequence RRNCSNIGVAQ, was essential for inducing 
the stalling (Ominato et al., 2002). Located 6 residues N’ terminal to Ser-94, at the 
time of the stall, this peptide most likely occupies the tunnel constriction. Although 
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there are no structural studies of the CGS1 nascent peptide in the ribosome tunnel, it 
is conceivable that similarly to other regulatory schemes involving nascent peptides 
such as TnaC in E. coli, when in high concentration AdoMet interacts with the 
nascent peptide in the tunnel. This putative interaction may stabilise specific 
contacts with the tunnel components that trigger allosteric changes, resulting in 
rearrangements in the PTC. Therefore, the translating ribosome with CGS1 nascent 
peptide in the tunnel could act as a sensor for AdoMet levels. 
 It was demonstrated that at least two ribosomes are tightly stacked behind the 
one stalled at Ser codon at position 94 (Yamashita et al., 2014). In addition, a variety 
of 5’ degradation intermediates were identified for CGS1 mRNA. These and other 
findings are supportive of ribosome stacking inducing RNA degradation (Yamashita 
et al., 2014). The translation profile of CGS1 mRNA shown in figure 3, confirms the 
strong pause at Ser-94, already demonstrated by different techniques.   
 
 
 
 
 
 
Figure 2.3: Ribo-seq (red) and mRNA-seq (green) coverage in the first part of the 
first exon of CGS1 gene in Arabidopsis thaliana. The light blue panel indicates the 
stalling site that takes place during translation elongation at serine at position 94. 
 
2.3.2 MAGDIS 
 
S-adenosylmethionine decarboxylase (AdoМet DC) is one of the key enzymes in 
polyamine biosynthesis (Pegg, 2009b). AdoМet DC catalyses the decarboxylation of 
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S-adenosyl methionine (AdoMet or SAM). The decarboxylated S-adenosyl 
methionine (dcAdoMet) has a single known function in the cell, which is of a donor 
of aminopropyl groups for the synthesis of spermidine from putrescine and that of 
spermine from spermidine. The reactions are catalysed by spermidine and spermine 
synthases respectively (Pegg, 2009b).  
 dcAdoMet is committed to polyamine synthesis and its production is a rate 
limiting step for this process. Therefore, AdoMet DC expression levels are finely 
tuned. Regulation of transcription and protein half-life are important aspects. The 
translation of AdoMet DC mRNA provides an additional layer of regulation that 
employs a nascent peptide responsive to polyamine levels (Hill and Morris, 1993, 
Ruan et al., 1996). 
 The nascent peptide occurs in a six codon ORF upstream of the main coding 
ORF. This encodes the peptide sequence MAGDIS, which is used to refer to the 
nascent peptide. Mutational analysis of MAGDIS has identified the amino acid 
residues essential for stalling (Mize et al., 1998). Aspartate (D) and Isoleucine (I) at 
positions 4 and 5 are almost obligatory for stalling; altering the aspartate residue to 
any other amino acid disables stalling. Isoleucine at position 5 may only be 
substituted with a valine residue. Many amino acid residues were tolerated at 
position 6 (Mize et al., 1998). The strict requirement for particular amino acid 
residues at those two positions and the fact that these are the two most conserved 
residues, suggests that these in particular might be involved in interactions with 
components of the translational machinery in the vicinity of PTC, resulting in 
ribosome stalling (Fig.2.4). The stalling is enhanced in the presence of high 
polyamine levels suggesting that polyamines can stabilise the putative interactions 
of the nascent peptide and the ribosome. 
 Just six residues long, MAGDIS occupies only the upper portion of the exit 
tunnel. By comparison to other stalling peptides for which structural data exists, the 
conserved MAGDIS residues at positions 4 and 5 should be located in the vicinity of 
U2585 and A2062 at the time of stalling. It is conceivable that polyamines when in 
high levels in the tunnel, facilitate or promote a specific conformation of the nascent 
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peptide such that would stabilise specific contacts with tunnel residues which then 
result in stalling.   
 The regulatory uORF’s initiation codon is positioned unusually close to the 
mRNA cap - only about 14 nucleotides from it. Initiation at AUG codons located 
very close to the 5’cap is known to be less efficient (Kozak, 1991a, Kozak, 1991b) 
owing to ribosomes failing to recognise the initiation codon. It has been tempting to 
speculate that the position of the uORF starting so close to the cap is a component of 
the polyamine regulation. However, it has been shown to be used independently 
from the polyamine response and is a mechanism for tuning mRNA expression in 
cell specific manner. In lymphoid T cells, ribosomes easily recognise, and initiate at, 
the uORF AUG which results in strong suppression of the main ORF translation. 
AdoMet DC mRNA from these cells was found primarily in the monosome fraction 
(Ruan et al., 1994). In non-lymphoid cells, where a large proportion of ribosomes 
fail to initiate at the uORF start due to the close proximity to the cap, and therefore 
reach the main coding region, AdoMet DC mRNA is found to be associated with 
polysomes (Ruan et al., 1994).  
 
 
 
 
 
 
 
 
 
 
Figure 2.4: Ribo-seq and mRNA-seq coverage in the first exon of the gene encoding 
AdoMet DC. The two blue panels indicate translation of the uORF encoding the 
peptide MAGDIS and the main ORF respectively. Ribosome coverage representative 
of an aggregate of multiple experiments is shown in red. The corresponding mRNA-
seq coverage is in green. 
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2.3.3 AAP 
 
Carbamoyl phosphate synthetase catalyses the first step committed to arginine (Arg) 
biosynthesis. In fungi e.g. Neurospora crassa, the translation efficiency of the small 
subunit of the heterodimer enzyme is regulated by the translation of an uORF in the 
5’ leader region. The uORF encoded arginine attenuator peptide (AAP) functions 
from within the ribosome tunnel to stall the ribosome in the presence of high levels 
of free Arg (Wang and Sachs, 1997) (Fig.2.5). Ribosomes stalled at the end of the 
AAP coding sequence block the following ribosomes from reaching the main ORF 
AUG downstream (Wang and Sachs, 1997) thus reducing the expression of the main 
ORF.  
 The AAP encoding uORF has been found to be conserved among fungi but 
not outside of the group (Hood et al., 2007). In the presence of high Arg levels, 
ribosomes stall (Spevak et al., 2010) with the uORF stop codon in the A-site (Wang 
and Sachs, 1997). However AAP preserved its stalling potential even when the AAP 
encoding sequence was fused to a reporter gene or placed internally (Wang et al., 
1998b), suggesting that impairment of the peptidyl hydrolysis reaction may not be 
the reason for the observed stalling. A puromycin release assay suggested that, 
translation of AAP in high Arg conditions results in either inhibition of the peptidyl 
transferase activity of the PTC or in restricted access to the A-site.  
The N. crassa AAP is 24 amino acids long and has the sequence: 
1MNGRPSVFTSQDYLSDHLWRALNA24, where crucial residues are in bold. 
Mutational analysis revealed that the minimum domain needed for the regulatory 
response to Arg levels is comprised of AAP residues 9-20 (Spevak et al., 2010). 
Mutating Asp-12, Tyr-13, Lys-14 and Trp-19 has been shown to abolish the 
regulation in response to high Arg (Spevak et al., 2010). Interestingly AAP variants 
extended by one amino acid or shortened by one or two amino acids also had an 
inhibitory effect on PTC activity. Truncated or extended AAP variants were also 
capable of stalling the ribosome, but less efficiently. Such flexibility is unusual since 
the general understanding is that for stalling to occur, key residues of the nascent 
peptide contact specific tunnel components. Hence the spacing between the key 
residues and the P-site is considered to be critical for nascent peptide function.    
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A possible explanation of such flexibility may come from structural studies 
of the AAP nascent peptide in the ribosome tunnel. Two prominent areas of contacts 
between tunnel components and AAP residues were identified. In the constriction 
area, Asp-12 and its neighbour residues form contacts with L17 and L4 residues as 
well as with rRNA nucleotides such as A751. The second prominent area is further 
in the upper tunnel where U2609 and A2062 contact Trp-19 and its neighbour 
residues. Extensive contacts between a large number of AAP residues with the 
tunnel components in the constriction and the upper tunnel areas may explain why 
shifting of the nascent peptide by one or two amino acid residues does not fully 
abolish stalling.  
In addition, structural data of the AAP nascent peptide within the ribosome 
exit tunnel revealed that the nascent peptide communicates with the upper tunnel 
nucleotides U2585 and A2062 (Bhushan et al., 2010).  
Similar to other eukaryote arrest peptides such as CMV as well as the 
bacterial TnaC and SecM, mutations in L22 or insertions in the A751 region 
abolished peptide mediated stalling. This is consistent with an important role of the 
constriction area for nascent peptide mediated ribosome stalling.  
Structural analysis of the AAP nascent peptide within the exit tunnel has 
revealed that D12 forms contacts with residues and L17 (eukaryote homolog of L22) 
as well as with the nucleotide A751 (bacterial numbering) in the constriction area. 
Structural studies of the AAP nascent peptide within the exit tunnel in the presence 
of high levels of Arg are still not available. However, it is conceivable that similar to 
the bacterial TnaC stalling system AAP forms Arg binding pockets within the tunnel. 
With high Arg concentration, binding of Arg in the pockets would result in 
stabilisation of nascent peptide contacts resulting in stalling. 
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Figure 2.5: Translation of the AAP encoding uORF in CPA1 gene of S. 
cerevisiae is detectable with ribo-seq data. Location of uORF (upstream) and main 
ORF (downstream) regions is indicated by the light blue panels. Red depicts 
ribosome coverage representative of an aggregate of multiple experiments. In green 
is the corresponding mRNA-seq coverage.    
2.3.4 Antimicrobial peptides 
 
Proline rich antimicrobial peptides are a class of small peptides that plants and 
animals have evolved as part of their natural defence against microbes. These are 
currently being extensively studied due to the potential use of antimicrobial peptides 
as an alternative to antibiotics. Recent studies have revealed the structure of oncocin 
Onc112 in complex with the bacterial ribosome. Onc112 was found to be positioned 
within the protein exit tunnel similarly to the nascent polypeptide chain during 
translation. However Onc112 orientation in the tunnel was reverse, its N-terminus 
was localised in the PTC near the A-site while its C-terminus was positioned at the 
vicinity of the tunnel constriction. Similarly to some regulatory nascent peptides 
discussed earlier as well as to antibiotics that bind within the ribosome tunnel, 
Onc112 establishes various interactions with components of the PTC and the exit 
tunnel. These interactions result in disturbance of the PTC function and prevent the 
proper positioning of the upcoming aminoacyl-tRNAs (Roy et al., 2015).  
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2.4 Conclusion 
The nascent peptide within the ribosome exit tunnel can alter ribosome behaviour. 
This feature is employed by the translation machinery to fine tune specific mRNA 
expression according to cellular needs. The interactions of various molecules such as 
amino acids and antibiotics with the nascent peptide in the tunnel, are transformed 
into instructions that navigate the ribosome to alter its behaviour in response to 
changes in the environment. In this way the translating ribosome with specific 
nascent peptide sequences in the tunnel, functions as a sensory machine which 
integrates environmental cues into regulatory response to fine tune the translation of 
specific mRNAs. Not only is this feature of the translating ribosome shedding light 
on a dynamic regulatory mechanism that takes place during protein translation but 
also it generates a better mechanistic understanding of how the ribosome itself 
functions.  
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Chapter 3 
Polyamines and their regulation  
 
3.1 Introduction 
 
In 1678 Antoni van Leeuwenhoek looked under his primitive microscope and 
described the occurrence of crystalline structures in human semen. These were 
composed of what would later be identified as a phosphate of the polyamine 
spermine. One can easily imagine Leeuwenhoek’s astonishment if he were to know 
that the structures he observed were made of a molecule that belongs to the group of 
polyamines, now known to be indispensable regulatory molecules in the living cell. 
Even more surprising however is the fact that over 300 years after Leeuwenhoek’s 
observation and almost 100 years since polyamines structure was uncovered 
(Rosenheim, 1924), it is still not known precisely how polyamines exert their 
functions.  
 Polyamines are a class of molecules with aliphatic chains and more than two 
amino groups. Diamines such as putrescine and cadaverine are often referred to as 
polyamines which is misleading because they have only two amino groups. At 
physiological pH the amino groups are mainly protonated and therefore polyamines 
can be described as organic polycations. The polyamines spermidine and spermine 
and their precursor the diamine putrescine, are present in mammalian tissues (Pegg 
and Casero, 2011). Spermidine and spermine are also the most common polyamines 
in higher plants (Gill and Tuteja, 2010). Fungi such as Ustillago maydis contain 
spermidine but not spermine (Valdes-Santiago et al., 2012). Thermophile bacteria 
contain a wide variety of polyamines, including the longer caldopentamine and 
caldohexamine, and the more unusual, branched polyamines such as tetrakis (3-
aminopropyl) ammonium (Oshima, 2007). Various combinations in different ratios 
of these and other naturally occurring diamines and polyamines are present in 
virtually all living cells.  
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Polyamines are involved in multiple cellular processes (Pegg, 2009a). Due to their 
positive charges, polyamines interact with macromolecules with acidic nature such 
as nucleic acids, membrane phospholipids and some proteins. Indeed, polyamines 
are found mostly bound to DNA and RNA. Due to their polycationic nature, 
polyamines bind DNA and neutralise the phosphate charges, with polyamine levels 
altering the condensation state of DNA (Raspaud et al., 1998). It has been shown 
that polyamines can promote transition between A, B and Z double helical structures 
of DNA by stabilizing one of them over the others (Ali and Ali, 1996, Bryson and 
Greenall, 2000, Thomas et al., 1991). In thermophilic bacteria polyamines serve to 
stabilize nucleic acids in conditions of high temperature (Oshima, 2007). 
Polyamines were also found to affect chromatin condensation and remodelling 
(Sarkar et al., 2009, Fredericq et al., 1991, Hobbs et al., 2002). These functions are 
suggestive of a general involvement of polyamines in modulation of gene expression 
by altering the efficiency of gene transcription through changes in DNA structure 
and chromatin condensation. Therefore transcription of many genes is anticipated to 
be, and indeed is, affected by polyamines (Wallace et al., 2003, Childs et al., 2003, 
Janne et al., 2004).      
 RNA is similarly bound and stabilised by polyamines and this could have an 
effect on protein translation through alteration of mRNA secondary structure and/or 
ribosome function (Pegg, 2009a). Specific cases of polyamine regulation of 
translation, mostly of genes connected with polyamine metabolism, have been 
identified and well-studied (Ruan et al., 1996, Ivanov et al., 2000). However, it is 
becoming apparent that polyamines have a much more general effect on translation. 
The ‘polyamine modulon’ in bacteria refers to genes whose expression was affected 
by polyamines at the level of translation (Yoshida et al., 2004). In fact, the 
‘polyamine modulon’ concept could be naturally extended to yeast and mammals.  
 The ubiquitous distribution and extensive interaction of polyamines with 
nucleic acids and other macromolecules and their participation at every level of gene 
expression makes the identification of the exact biochemical roles a very difficult 
task. Our understanding of the precise mechanism of polyamine action lags behind 
that of other important regulatory molecules. 
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 One of the ways polyamines can influence translation is through the 
translation factor eIF5A (Dever et al., 2014). As its name reveals, it was first thought 
to be an initiation factor that stimulated the f-Met-puromycin formation and the 
transition from late initiation to elongation (Benne and Hershey, 1978). Later on it 
was revealed that eIF5A was actually acting to facilitate elongation. Therefore it was 
recently proposed that the factor be renamed to eEF5 which stands for eukaryote 
elongation factor 5 (Dever et al., 2014). eEF5 is the sole known protein to utilise the 
posttranslational modification namely hypusination, the substrate for which is the 
polyamine spermidine. Despite many years of research, mystery still surrounds this 
translation factor and its functions. Various functions have been assigned to eEF5 
and for all of them the unusual spermidine derived hypusine modification appears to 
be crucial. In S. cerevisiae polyamine auxotrophs, the effect of spermidine 
supplementation on cellular growth was primarily mediated by the hypusine 
modification of eEF5 (Chattopadhyay et al., 2008). Increased levels of the two 
isoforms of eEF5 were identified in many cancers and were promoted as tumour 
markers (Mathews and Hershey, 2015). In a recent study, sulphated eEF5 was found 
to function as a humoral apoptosis promoting factor in conditions of oxidative stress 
(Seko et al., 2015). In addition, studies have suggested that similarly to its bacterial 
homolog EFP, eEF5 is required for efficient translation of polyproline stretches 
(Gutierrez et al., 2013, Doerfel et al., 2013, Ude et al., 2013).   
   Early studies revealed that polyamines have a stimulatory effect on the 
growth of bacteria (Herbst and Snell, 1948, Martin et al., 1952, Kihara and Snell, 
1957). In E. coli hundreds of genes were upregulated in response to polyamines, 
many of them at the level of transcription. Those upregulated at the translation level 
were assigned to the so called ‘polyamine modulon’ (Yoshida et al., 2004). Among 
these, there were genes with weak or not optimally positioned Shine-Dalgarno 
sequence, for which enhanced polyamine levels increased translation efficiency. 
Optimisation of SD sequence and its position, resulted in a loss of polyamine 
regulation. This is consistent with a model for polyamines altering RNA structure to 
overcome the suboptimal positioning of SD and stimulating the initiation efficiency 
(Yoshida et al., 2004). 
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 In eukaryotes polyamines are absolutely required for cell growth and 
proliferation, as revealed by knockouts of the main polyamine biosynthetic enzymes 
in mice which had lethal effect in early days of embryonic development (Pegg and 
Casero, 2011). However too much of a good thing can be harmful and increased 
levels of polyamines and/or of polyamine biosynthetic enzymes such as ornithine 
decarboxylase (ODC) were found in many tumours. These findings stimulated an 
extensive research aiming to identify the connections between polyamine pathways 
and cancer (Bachrach, 2004). Anti-cancer compounds were developed that target 
important enzymes in the polyamine biosynthesis (Babbar and Gerner, 2011). Such 
is the case of D,L-alpha-difluoromethylornithine (DFMO) which was developed for 
cancer treatment in the late 1970s. DFMO is an analogue of the substrate for ODC 
and acts as an irreversible inhibitor of this enzyme. However DFMO proved to have 
only modest therapeutic effect and induced side toxicity effects. Despite this, the 
interest in DFMO in regard to cancer has not ceased although it has shifted from its 
therapeutic potential toward that of a chemoprevention agent, and the latter is being 
extensively explored (Meyskens and Gerner, 1999, Bailey et al., 2010). DFMO, also 
known as Eflornithine was shown to be a potent drug against Human African 
trypanosomiasis (HAT), also known as sleeping disease (Bacchi, 2009, Bacchi et al., 
1980).   
 Recent study has revealed the interdependence of polyamine metabolism and 
circadian rhythmicity in mammals (Zwighaft et al., 2015). In cultured cells, 
polyamine content had an effect on the circadian period with low polyamine levels 
found to correlate with longer circadian period. The observed effect was reverted 
upon polyamine supplementation.  Such longer circadian period was observed in 
older mice where it correlates with reduced polyamine levels in older animals. Key 
enzymes from the polyamine metabolism such as ODC, SPD SYN, and AMD1 and 
their products, mainly putrescine and spermidine, were found to be produced in a 
cyclic manner daily. This daily oscillation of the enzymes and the corresponding 
products was affected by key regulators of the circadian rhythmicity (Zwighaft et al., 
2015).  
 Polyamine biosynthesis begins with arginine. Arginine is transformed 
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through ornithine into putrescine and the second half of this reaction is catalysed by 
ornithine decarboxylase (ODC) (Fig.3.1). In an alternative route utilised by plants, 
arginine is decarboxylated by arginine decarboxylase to produce agmatine. The 
latter is then converted to putrescine by the enzyme agmatinase.  
 Putrescine is then utilised as a substrate for the synthesis of the polyamines 
spermidine and spermine (Fig.3.1).  The main route for polyamine biosynthesis 
utilised by mammals, plants, yeast, archaea and many bacteria was identified in 
Celia and Herbert Tabor’s laboratory (Tabor et al., 1958). In this route, putrescine 
was identified as the source of the diaminobutane moiety in spermidine and 
spermine, while decarboxylated S-adenosylmethionine (dcSAM or dcAdoMet) was 
identified as the source of the terminal aminopropane moiety in these compounds 
(Tabor et al., 1958) (Fig.3.1). Two aminopropyl transferases, spermidine and 
spermine synthases, catalyse the transfer of aminopropyl groups from dcAdoMet to 
putrescine or spermidine for the production of spermidine and spermine respectively. 
A second route for polyamine biosynthesis was later described to occur in many 
other bacteria (Tait, 1976). It does not rely on dcAdoMet as an aminopropyl 
substrate and the species that utilise this route lack the enzyme catalysing the 
reaction of AdoMet decarboxylation, namely AdoMet decarboxylase (AdoMetDC).  
 Reducing the levels of polyamines includes degradation and export promoted 
by enzymes of the polyamine catabolism. This begins with the acetylation of 
spermidine and spermine by spermidine/spermine N1-acetyltransferase (SSAT), a 
major catabolic enzyme of the polyamine pathway (Casero and Pegg, 2009) 
(Fig.3.1). The products of the acetylation reaction, N1-acetylspermidine, N1-
acetylspermine and N1, N12-diacetylspermine, are exported. In addition, N1-
acetylspermidine and N1-acetylspermine are converted to putrescine and spermidine 
respectively by N1-acetylpolyamine oxidase (APAO). Another catabolic enzyme, 
spermine oxidase (SMO) efficiently converts spermine to spermidine, which can 
then be acetylated by SSAT and converted to putrescine by APAO. Putrescine is a 
smaller molecule which is easier to export. In addition, putrescine can be degraded 
by diamine oxidase (Fig.3.1). 
 The enzymes for polyamine synthesis and catabolism are very well regulated 
                                                  
                                                                                
                                                                                 
 
 
69 
 
 
at the levels of transcription, translation, and protein turnover. A plethora of 
regulatory events that takes place during translation includes the involvement of 
uORFs, stalling nascent peptides, and even a programmed recoding event. The 
function and regulation of the main enzymes in the polyamine pathway will be 
further reviewed in more detail. 
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Figure 3.1: Polyamine metabolism 
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3.2 Enzymes of the polyamine metabolism and their regulation  
 
3.2.1 Ornithine decarboxylase (ODC) 
 
ODC is a pyridoxal phosphate dependent amino acid decarboxylase that catalyses 
ornithine decarboxylation to produce putrescine (Pegg, 2006) (Fig.3.1). Since 
putrescine is a substrate for the synthesis of the polyamines spermidine and 
spermine, the ODC catalysed reaction is a critical step in polyamine biosynthesis. 
Therefore, and not surprisingly, ODC synthesis and degradation are highly 
regulated. 
 ODC degradation is very rapid, with protein half-life in mammals of less 
than one hour (Pegg, 2006). The active form of the enzyme is a homodimer. A key 
point of ODC regulation in response to polyamine levels is its ubiquitin independent 
proteasomal degradation, directed by the protein antizyme (Murakami et al., 1992). 
In high polyamine levels antizyme binds to ODC monomers and exposes a 
degradation signal, recognised by the proteasome, resulting in proteasomal 
degradation without the need for ubiquitination (Wu et al., 2015, Takeuchi et al., 
2008, Kahana, 2007). The ODC degradation signal was found to occur at the C-
terminus in mammals (Ghoda et al., 1989) but at the N-terminus in S.cerevisiae 
(Godderz et al., 2011). Antizyme translation is regulated by polyamine 
concentrations via an unusual translational event featuring frameshifting which will 
be described in more detail in a section covering antizyme. In addition, in low 
polyamine levels, antizyme in its turn is downregulated by antizyme inhibitor, an 
ODC homolog, which binds with strong affinity to antizyme and sequesters it 
(Lopez-Contreras et al., 2006) (Fig.3.2). 
 ODC transcription levels are altered in response to a wide range of stimuli 
such as growth factors, hormones, oncogenes and others (Pegg, 2006, Miller-
Fleming et al., 2015). The ODC gene promoter contains various sequence elements 
that allow for binding and response to different factors. For example the ODC 
promoter has two CACGTG E-boxes to which the oncogene product c-Myc binds in 
complex with its partner Max (Wagner et al., 1993, Nilsson et al., 2004). In addition, 
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the heterodimeric transcriptional activator, BMAL1:CLOCK, a key component of 
the circadian rhythmicity in mammals (Huang et al., 2012), was found to also bind 
to E-box motifs in the ODC gene. This promotes the rhythmic transcription of ODC, 
shown to be a component of the circadian clock control (Zwighaft et al., 2015)  
 ODC mRNA has a long and highly structured 5’UTR that was shown to have 
an inhibitory effect on translation (Pegg, 2009a). A conserved uORF was found in 
the 5' leaders of ODC in animals other than mammals and in some fungi (Ivanov et 
al., 2008). In most cases it was initiated by AUU or by an AUG in a week Kozak 
context. This conserved uORF may provide an additional layer of regulation in 
response to polyamine levels, just as it does for antyzime inhibitor, as discussed 
below.  
  
3.2.2 Antizyme inhibitor (AZIN) 
 
AZIN is an ODC homolog that has lost its decarboxylase activity (Murakami et al., 
1996) but has a greater affinity for binding AZ, compared to ODC. AZIN binds and 
sequesters AZ, disrupting or preventing the formation of complexes with ODC, 
hence limiting AZ inhibitory effect on polyamine synthesis (Fig.3.2). In mammals 
there are two AZIN paralogs namely AZIN1 which is present in all tissues and 
AZIN2 which is present in brain and testis (Lopez-Contreras et al., 2010). Deletion 
of AZIN1 in mice was shown to lead to ODC degradation and critically reduced 
levels of putrescine and spermidine and has a lethal effect (Tang et al., 2009).  
 Polyamine levels have similar inhibiting effects on AZIN and ODC. In the 
presence of elevated polyamine levels, the AZIN synthesis is downregulated and AZ 
becomes available for binding ODC and targeting it for degradation.  
 Sequence analysis of vertebrate AZIN1 5' leaders revealed the occurrence of 
a conserved uORF of about 50 codons, starting with an AUU codon positioned in a 
good Kozak context (Ivanov et al., 2008). The C-terminal end of the uORF encoded 
polypeptide is highly conserved with two prominent sequential proline residues 
followed by a tryptophan. 
 The regulatory potential of the conserved uORF was experimentally tested 
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for the mouse AZIN1 sequence (Ivanov et al., 2008). In the presence of elevated 
polyamine levels, the uORF significantly reduced translation of the main ORF. The 
repression was relieved upon substitution of the AUU initiator codon with a non- 
initiator codon, UUU. Likewise, substitution of the start codon AUU with AUG in 
an optimal Kozak context precluded downstream main ORF translation. Importantly, 
the inhibitory effect in the presence of high polyamine levels was lost when the 
sequence encoding for the last 10 amino acids was placed out-of-frame (Ivanov et 
al., 2008). These observations are consistent with a model in which the conserved 
nascent peptide acts from within the ribosome protein exit tunnel in concert with 
polyamines to stall ribosomes translating the uORF. The stalled ribosomes would 
present a physical barrier for scanning ribosomes to reach the downstream main 
ORF start codon, consistent with the observed reduction of main ORF translation 
(Ivanov et al., 2008).  
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Figure 3.2: Schematic representation of the interactions between ODC, AZ and 
AZIN, crucial for polyamine homeostasis. Antizyme binds ODC monomers and 
targets them for ubiquitin independent degradation by the 26S proteasome. Antizyme 
also regulates the polyamine membrane transporter by inhibiting polyamine uptake 
and stimulating polyamine excretion. AZI binds and sequesters AZ. Antizyme protein 
synthesis requires translational frameshifting which is stimulated by free 
intracellular polyamines. This event completes an auto regulatory circuit. 
 
3.2.3 S-Adenosylmethionine decarboxylase (AdometDC) 
 
The aminopropyl transferases, spermidine and spermine synthase, utilize 
decarboxylated S-adenosylmethionine (dcAdoMet) as a donor of aminopropyl 
groups to produce the polyamines spermidine and spermine respectively from 
putrescine (Fig.3.1). S-Adenosylmethionine decarboxylase (AdoMetDC) is thus a 
rate limiting enzyme in polyamine synthesis, since it catalyses the production of 
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dcAdoMet, which is committed to polyamine synthesis (Pegg, 2009b) (Fig.3.1). 
 The translation of AdoMetDC mRNA yields an AdoMetDC proenzyme 
which undergoes a spontaneous cleavage at a conserved serine residue (Bale and 
Ealick, 2010). As a result of the internal serinolysis reaction, a large α subunit with a 
pyruvoyl group at the N-terminus and a small β subunit are produced (Bale and 
Ealick, 2010). The pyruvoyl group in the active site serves as a prosthetic group and 
provides for the decarboxylase activity of the enzyme, which belongs to the 
pyruvoyl type decarboxylases (Pegg, 2009b). The active form of the enzyme is 
comprised of two (αβ) heterodimers. In mammals and yeast putrescine has an 
activating effect on AdoMetDC as it stimulates the proenzyme cleavage as well the 
activity of the mature enzyme (Bale et al., 2008). In other organisms where 
putrescine is highly abundant, it does not have the same stimulatory effect upon 
AdoMetDC (Pegg, 2009b). Structural studies have revealed that putrescine binds 
AdoMetDC within a pocket distanced from the active site (Bale et al., 2008). There 
is one putrescine binding site per (αβ) heterodimer. Upon binding, putrescine 
triggers rearrangements of the residues connecting the putrescine binding pocket and 
the active site. The activation effect is thus a result of triggering the favourable 
positioning of the catalytic residues in the active site.  
 AdoMetDC is another enzyme of the polyamine pathway that is very well 
regulated. Since dcAdoMet is utilised almost entirely for polyamine synthesis, while 
its precursor AdoMet is used as a methyl group donor in numerous reactions, the 
levels of AdoMetDC are kept low and decarboxylated AdoMet corresponds to only 
about 1% of the AdoMet cellular pool  (Pegg, 2009a).  
 Probably the best studied aspect of AdoMetDC regulation involves a uORF 
encoded nascent peptide with the amino acid sequence MAGDIS. The ribosome 
translating this uORF in the presence of high polyamine levels is stalled and as in 
the case of AZIN1, this results in inhibition of the translation of the downstream 
main ORF. The MAGDIS mediated regulation of AdoMetDC was discussed in more 
detail in the previous chapter covering regulatory nascent peptides. 
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3.2.4 Spermidine-spermine-N1-acetyltransferase (SSAT)  
 
SSAT is the main catabolic enzyme in polyamine metabolism (Pegg, 2008). Along 
with ODC and AdoMetDC, SSAT is another enzyme crucial for maintaining 
polyamine homeostasis. SSAT acetylates spermidine and spermine thus reducing 
their charges and facilitating their excretion. In addition to being excreted, these 
acetylated products are substrates for oxidation by APAO (Pegg, 2008) (Fig.3.1).  
 SSAT mRNA levels are normally kept low in the cell with low constitutive 
expression of SSAT. In the presence of high polyamines, SSAT transcription is 
elevated through the interaction of transcription factors with a cis-acting polyamine 
response element (PRE) found upstream of the transcription start site in the SSAT 
gene (Wang et al., 1998a, Wang et al., 1998b, Wang et al., 2001).  
 SSAT levels are highly regulated. In addition to transcription other levels of 
regulation include mRNA stability and protein turnover as well as translation (Pegg, 
2008). Studies revealed an intriguing control mechanism involving a repressor 
protein bound to a stem loop in the 5’ coding region in SSAT mRNA (Perez-Leal et 
al., 2012). With high polyamine levels the protein dissociates and translation can 
resume.  
 It was suggested that translation regulation did not depend on the presence of 
the 5’ or 3’UTRs. However, two uORFs were identified to occur in vertebrates 
(Perez-Leal et al., 2012, Ivanov et al., 2010). The longer one is in +1 frame and 
overlaps the main ORF. The second one which is further upstream and is only 4 
codons long seems to be highly translated as illustrated with ribo-seq data obtained 
from Gwips-viz (Fig.3.3).  
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Figure 3.3: Ribo-seq (red) and mRNA-seq (green) coverage in the 5’ UTR and the 
first part of the main ORF of ssat1 gene. The left blue panel indicates the short 
uORF and the blue panel to the right indicates the first part of the main ORF. 
 
3.2.5 Antizyme (AZ) 
 
The protein antizyme occurs in cells from yeast to mammals. It targets specific 
proteins for ubiquitin-independent proteasome-mediated degradation. Its best known 
interaction is with ODC and with the exception of plants, where it is not present, 
antizyme is a key regulator of ODC activity and as such it is a very important 
regulator of cellular polyamine homeostasis (Ivanov and Atkins, 2007). In addition 
to its effect on ODC, antizyme inhibits the import, and stimulates the export, of 
polyamines through the cellular membrane (Sakata et al., 2000). 
 A remarkable mechanism for sensing cellular free polyamine levels features 
translation of antizyme mRNA. Antizyme mRNA contains two partially overlapping 
open reading frames (ORFs). Expression of biochemically active antizyme requires 
translation of ORF2 (Miyazaki et al., 1992, Ichiba et al., 1994). In cells this is 
accomplished via translational frameshifting occurring at the end of ORF1 
(Matsufuji et al., 1995). The rate of the frameshifting event is determined by the 
levels of free polyamines in the cell. High levels of free polyamines stimulate the 
frameshifting efficiency in decoding antizyme mRNA resulting in an increased 
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synthesis of antizyme protein. Through its inhibition of ODC, antizyme triggers a 
decrease of free polyamine levels in the cell. Likewise, low concentrations of free 
polyamines result in low antizyme mRNA frameshifting efficiency, allowing ODC 
and transporter activities to restore free polyamine levels (Fig.3.2). Thus the 
frameshifting is a sensor and effector in a polyamine induced auto regulatory circuit 
involved in maintaining the homeostasis of the free polyamines in the cell (Ivanov 
and Matsufuji, 2010, Coffino, 2001) (Fig.3.2).  
As a negative regulator of cellular polyamine levels, antizyme is an inhibitor 
of cell proliferation and transformation. It was demonstrated that antizyme induces 
the ubiquitin-independent degradation of the anti-apoptotic protein DeltaNp73 
which is very relevant to resistance of tumor cells to chemotherapeutic drugs. 
Degradation of DeltaNp73 through the antizyme induced ubiquitin independent 
pathway is stimulated by transcription factors such as c-Jun by a mechanism that 
was only recently unravelled (Bunjobpol et al., 2014). It features C-Jun mediated 
inhibition of acetylpolyamine oxidase (PAOX), an enzyme of the polyamine 
catabolism.  
 Given the importance of the small organic polycations, polyamines, for a 
wide range of cellular processes, and probably other roles of antizyme, it is not 
surprising that antizyme synthesis is itself highly regulated. The level of antizyme is 
governed in several ways including sequestration by AZIN, whose own synthesis is 
polyamine regulated (Fujita et al., 1982, Kahana, 2009), by C-Jun effects on 
polyamine catabolism (Bunjobpol et al., 2014), and by the level of its own synthesis 
being responsive to polyamine levels. This response is mediated by the relative 
efficiency of a programmed shift of ribosomal reading frame necessary to synthesize 
functional antizyme since it is encoded in two different, and partially overlapping, 
reading frames (Fig. 3.2) (Matsufuji et al., 1995). The frameshifting involved is a 
crucial sensor and effector of an autoregulatory circuit with elevated polyamines 
resulting in the synthesis of more antizyme which dampens both the synthesis and 
uptake of polyamines. cis-acting elements in antizyme mRNA are required for 
optimal frameshifting efficiencies. Curiously, a recent study has revealed that 
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frameshifting efficiency in C. elegans antizyme was induced in stress conditions 
such as starvation, and independent of polyamine levels (Stegehake et al., 2015)  
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Chapter 4 
A nascent peptide signal responsive to endogenous 
levels of polyamines acts to stimulate regulatory 
frameshifting on antizyme mRNA 
 
This chapter has been published in J Biol Chem. 2015 Jul 17;290(29):17863-78. 
 
The protein antizyme is a negative regulator of cellular polyamine concentrations in 
eukaryotes.  Synthesis of functional antizyme requires programmed +1 ribosomal 
frameshifting at the 3’ end of the first of two partially overlapping ORFs. The 
frameshift is the sensor and effector in an auto-regulatory circuit. Although the 
frameshift site alone only supports low levels of frameshifting, the high levels 
usually observed depend on the presence of cis-acting stimulatory elements located 
5’ and 3’ of the frameshift site. Antizyme genes from different evolutionary 
branches have evolved different stimulatory elements. Prior and new multiple 
alignments of fungal antizyme mRNA sequences from the Agaricomycetes class of 
Basidiomycota show a distinct pattern of conservation 5’ of the frameshift site 
consistent with a function at the amino acid level. As shown here when tested in S. 
pombe and mammalian HEK293T cells, the 5’ part of this conserved sequence acts 
at the nascent peptide level to stimulate the frameshifting, without involving stalling 
detectable by toe-printing. Yet the peptide is only part of the signal. The 3’ part of 
the stimulator functions largely independently, and acts at least mostly at the 
nucleotide level.  When polyamine levels were varied, the stimulatory effect was 
seen to be especially responsive in the endogenous polyamine concentration range.  
A conserved RNA secondary structure 3’ of the frameshift site has weaker 
stimulatory and polyamine sensitizing effects on frameshifting.  
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4.1 Introduction 
 
Notwithstanding some early antibiotic studies, shortly after determination of the first 
structure of the “tube” through which the nascent peptide passes from the internal 
ribosome site of its synthesis to the ribosome’s exterior, the interior of this exit 
tunnel was thought to behave like “molecular Teflon” and not interact with nascent 
peptide sequence thereby allowing unimpeded peptide egress (Nissen et al., 2000). 
However, interactions do occur with certain specific amino acid sequences, and 
evolution has exploited this for diverse and important functions.  Here we explore 
the possibility that acting as a stimulatory signal for ribosomal frameshifting utilized 
positively for gene expression, can be added to this list. The work focuses on 
antizyme frameshifting. 
 Recoding signals serve to potentiate high levels of frameshifting at the 
relatively inefficient frameshift site at the end of ORF1 in most antizyme mRNAs. 
An exception is the budding yeast Saccharomyces cerevisiae, and presumably 
closely related species, in which the recoding signals serve to reduce, in a polyamine 
dependent manner, the inherently very high level of frameshifting at the shift site in 
budding yeast (Kurian et al., 2011). Effects of the nascent peptide within the exit 
tunnel of the ribosome that just synthesized it, are an important component of the 
negatively acting recoding signals in S. cerevisiae antizyme frameshifting (Kurian et 
al., 2011).  
In contrast to the nascent peptide effects in S. cerevisiae, all the 
experimentally investigated antizyme frameshifting signals from S. pombe to 
humans act at the RNA level (Ivanov et al., 2000). These recoding signals are both 
5’ and 3’ of the shift site. Different mRNA pseudoknots are strongly represented in 
the 3’ signals (Matsufuji et al., 1995, Ivanov et al., 2004). As judged by deletion 
analyses, the 5’ stimulatory sequence in rats involves 50 nucleotides immediately 
upstream of the frameshift site. Though all is required for optimal levels of 
frameshifting, the sequence of the 3 codons just 5’of the ORF1 stop codon have the 
greatest effect (Matsufuji et al., 1995). Comparative sequence analysis has revealed 
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that the 5’ stimulatory sequence has a modular structure with the different modules 
evolving independently in the different evolutionary clades with the closest module 
to the shift site, module A, being the most highly conserved (Ivanov et al., 2000). In 
contrast to the results from the deletion analysis, single nucleotide substitutions of 
what is now called module A of mammalian antizyme 1, showed only a modest 
effect on frameshift efficiency (Matsufuji et al., 1995). Without further experimental 
testing, it was considered possible that it may act via interaction with rRNA of the 
mRNA exit tunnel, based on the precedent of 5’ stimulators for other cases of 
frameshifting being known to act in this manner (Huang et al., 1988, Larsen et al., 
1994).  
  With the exception of one high level case of incidental bacterial 
frameshifting (Gurvich et al., 2011), all non-antizyme investigated viral and 
chromosomal cases of programmed frameshifting involve recoding signals that act 
at the RNA level. Nevertheless, prior phylogenetic analysis of one case of positively 
utilized frameshifting where stimulatory signals are required to boost frameshifting 
efficiency indicated a recoding signal that acts at the nascent peptide level. This 
analysis was of the antizyme mRNA sequence from the 10 species then known from 
the Agaricomycotina sub-phylum of Basidiomycota fungi. One of these species was 
Coprinopsis cinerea. A highly conserved region of about 40 nucleotides was 
identified and its 3’ boundary is approximately at the 5’ boundary of module A and 
so 5’ of the frameshift site. The pattern of conservation in this region suggested that 
it functions at the peptide level and not at the nucleotide level (Ivanov and Atkins, 
2007).  
  The putative 3’ stimulatory element is a potential RNA secondary structure 
starting 19 nucleotides downstream of the frameshift site. The structure consists of 
two directly adjacent stem-loops suggesting that they may co-axially stack on each 
other (Fig. 4.1 B,C and Fig. 4.2). Its position relative to the frameshift site suggests 
that it would be just outside the ribosome mRNA tunnel during the frameshift event 
(Ivanov and Atkins, 2007). With the exception of two recently described cases 
(Kiran et al., 2011, Li et al., 2014), this is different from the other previously 
described stimulatory structures that are located closer to the frameshift site and  
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Figure 4.1: Conservation of antizyme mRNA sequences from Basidiomycota, and 
their encoded products. A. An alignment of 35 ORF1 antizyme mRNA sequences was 
used to generate the nucleotide and amino acid logos shown here. 34 of these 
sequences belong to Agaricomycetes and 1 belongs to Dacrymycetes. Starting from 
the 3’ end of the nucleotide logo indicated are the ORF1 stop codon, the shift site, 
the sequence of module A and the conserved peptide encoding region. Other 
conserved features more distal to the shift site such as a conserved dipeptide and a 
conserved 5’ stem loop are also indicated. The gaps in the logos indicate that each 
nucleotide or amino acid residue occur with equal probability at the corresponding 
position. B. Alignment of 54 Basidiomycotal antizyme mRNA sequences 3’ of the 
shift site. The region shown here contains the conserved 3’RNA structure. The ORF1 
stop codon is in red, nucleotides of the predicted stem 1are in green, those of stem 2 
are in blue and the nucleotides of loop are in orange. Nucleotide variations in loop 
2 are highlighted in green. The correct reading frame is indicated in the first 
sequence of the alignment. The absolutely conserved four nucleotide sequence 
abutting stem 1 are shown in magenta. Completely conserved nucleotides are 
indicated by an asterisk below the alignment. The four sequences of the 
Tremellomycetes class that lack the potential RNA structure were left uncolored and 
were not taken into account when analyzing the alignment. C. The predicted 
secondary structure of the putative RNA stimulator, inferred from the alignment, 
featuring the Coprinopsis cinerea mRNA sequence; the coloring corresponds to that 
of the alignment. The underlined names are of the sequences used for the alignments 
in Fig. 2A. The scheme of the phylogenetic tree was adapted from Floudas et al. (29) 
and is not intended to indicate precise evolutionary distances and scales. P.taeda* 
refers to an EST derived from a Pinus taeda library that is in fact an 
Agaricomycetes contaminant of unknown identity. Dacryop.** stands for 
Dacryopinax sp.  
 
presumed to act from within the mRNA entrance tunnel at the mRNA unwinding 
site (Matsufuji et al., 1995).   
 As some nascent peptides pass through the ribosome peptide exit tunnel, 
specific residues interact with tunnel components which are mostly RNA. These 
interactions can modulate translation downstream from sequence encoding the 
interacting segment of the nascent peptide (Wilson and Beckmann, 2011). To what 
extent such consequences are influenced by ribosome conformational changes 
associated with the interactions, and to what extent by stalling of nascent peptide 
progression, is likely case specific. 
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Figure 4.2: Schematic representation of Agaricomycotina antizyme mRNA with 
conserved regions. The sequence used in the scheme is that of C.cinerea antizyme 
mRNA. Shown from the left are the ORF1 start codon, a conserved putative RNA 
structure occurring 106 nts 5’ of the shift site, the putative nascent peptide signal 
shown in a box, the module A sequence, shift site and ORF1 stop codon. 19 nts 3’ of 
the shift site, a conserved putative 3’RNA structure was previously identified. 
Below: Extent of the sequence present in 6 antizyme constructs used in this study. 
 
 
Antizyme homologs are present in diverse eukaryotic evolutionary branches, 
including in animals, fungi, and protists (Ivanov and Atkins, 2007, Ivanov et al., 
2000, Ivanov et al., 1998). However, there is no indication that antizyme is present 
in plants. Fungal antizymes sequences have been identified in six separate phyla - 
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Ascomycota, Basidiomycota, Glomeromycota, Zygomycota, 
Neocallimastigomycota and Blastocladiomycota (Ivanov and Atkins, 2007); (I.P. 
Ivanov and JFA unpublished results). The Basidiomycota phylum contains three 
subphyla: Pucciniomycotina, Ustilaginomycotina and Agaricomycotina. 
Agaricomycotina includes organisms like the white rot fungi that are the only 
organisms capable of substantial lignin degradation (Floudas et al., 2012), the 
Lingzhi mushroom (Ganoderma lucidum) used in the traditional Chinese medicine 
for more than 2000 years (Chen et al., 2012), tree root pathogens such as the major 
forest pathogen annosum root rot (Heterobasidion annosum) and Armillaria bulbosa 
– one of the largest and oldest of all organisms (Aanen, 2014), also mushrooms and 
others. Pucciniomycotina and Ustilaginomycotina contain plant pathogens such as 
cereal rusts (Puccinia graminis) and Corn smut (Ustilago maydis).  
          Prior work showed that antizyme frameshifting is reproducible in 
heterologous systems from S. pombe to mammalian cells (Ivanov et al., 1998) 
[though not in S. cerevisiae (Hayashi et al., 1996)]. The FS stimulatory pseudoknot 
present in a subset of invertebrates was confirmed by testing the oyster antizyme 
mRNA in mammalian cells. Polyamine levels can be manipulated in a refined 
manner in mammalian cells (Howard et al., 2001). The present study examines the 
frameshift stimulators in a subset of fungal antizymes. Currently there is no 
homologous system available for testing the fungal antizyme mRNAs being 
investigated here. Because the polyamine levels can not readily be manipulated so 
effectively in the closer related S. pombe, the experiments involving manipulation of 
the polyamine levels were performed in mammalian cells.       
 The ancient origin of frameshifting in the antizyme gene and its evolution are 
reflected in the large diversity of its cis-acting stimulatory elements. Exploration of 
antizyme sequences from the different branches provides insights to the means by 
which the evolution preserves the essential traits while it navigates through diverse 
possibilities.  
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4.2 Experimental procedures  
 
Sequence Assembly and Analysis. 
Sequences were obtained and processed as described previously (Ivanov et al., 
2008). Alignments were generated using Clustal Omega (Sievers and Higgins, 
2014). Nucleotide and amino acid logos were generated using WebLogo (Crooks et 
al., 2004). 
 
Plasmids 
Oligonucleotides were synthesized at IDT, UK. A synthesized antizyme gene with 
the sequence from Coprinopsis cinerea was purchased from Gen Script Corporation, 
New Jersey where it was cloned in the vector pUC57 using an EcoRV cloning 
strategy. This sequence was used as template to generate the WT sequence (WT), 
which in turn was used as template for generating the other clones. The amplicons 
were generated by standard one-step or two step PCR. All amplicons were digested 
with BglII and XhoI and cloned into BglII/XhoI-digested vector pDluc (Fixsen and 
Howard, 2010, Grentzmann et al., 1998). The vector pDluc contains Renilla and 
firefly luciferase genes, separated by a short cloning site. Both luciferases are under 
the control of an upstream SV40 promoter. The antizyme cassettes were inserted 
between the two luciferase genes such that the upstream Renilla luciferase is in-
frame with ORF1 of antizyme, while the downstream firefly luciferase is in-frame 
with ORF2. All constructs were transformed in E. coli strain DH5-α and were 
verified by sequencing with the primer PD1550. The in-frame (IF) controls were 
generated by using a template wherein the U of the ORF1 UGA stop codon was 
deleted. The antizyme construct from the Alanine scan series wherein the glycine 
codon at position -4 was substituted with an alanine codon was compared with the 
ShortWT IF control instead. For testing antizyme frameshifting in S.pombe, 
antizyme cassettes were designed using primers which introduced the restriction 
sites for BstE II and Kpn I at the 5’ and 3’ end of the amplicon respectively. 
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Following digestion the antizyme cassettes were cloned into BstE II/Kpn I-digested 
vector PIU-LAC between GST and lacZ (Ivanov et al., 1998). 
Cell culture and transfection. 
Human HEK293T cells were maintained as monolayer cultures, grown in DMEM 
supplemented with 10% FBS, 1mM L-glutamine and antibiotics at 37Cº in an 
atmosphere of 5% CO2. For dual luciferase assays 4x10
6
 HEK293T cells were 
plated in 10 cm tissue culture dishes. After 24 hours the cells were detached with 
trypsin, suspended in fresh media and transfected in triplicate with Lipofectamine 
2000 reagent (Invitrogen), using the 1-day protocol in which suspended cells are 
added directly to the DNA complexes in half-area 96-well plates. For each 
transfection the following was added to each well: 25 ng plasmid DNA, 0.2 μl 
lipofectamine 2000 in 25 μl OptiMem (Gibco). 4x104 cells in 50 μl DMEM, were 
added to the transfecting DNA complexes in each well. Transfected cells were 
incubated at 37 C in 5% CO2 for 20 hrs and assayed using the dual luciferase assay. 
For polyamine manipulation protocol, the cells were grown in the presence of 2.5 
mM difluoromethylornithine (DFMO) for 5 days prior to transfection. After the 
incubation with DFMO, the cells were transfected using the protocol described 
above. 4x10
4 cells in 25 μl DMEM, grown in the presence of 2.5 mM DFMO, were 
added to the transfecting DNA complexes in each well. Transfected cells were 
incubated at 37 C in 5% CO2 for 24 hrs. After 24 hrs, 50 μl fresh media was added 
containing 1 mM aminoguanidine, 2.5mM DFMO, and either no polyamines, or 
polyamines to achieve final concentrations specified by experimental requirements. 
The cells were incubated for an additional 20h before being assayed. 
Dual luciferase assay. 
To measure the frameshifting efficiency of antizyme mRNA cassettes, a dual 
luciferase assay was employed. Relative light units were measured on a Veritas 
Microplate Luminometer fitted with two injectors (Turner Biosystems). The firefly 
and Renilla luciferase assay buffers were prepared as described (Dyer et al., 2000). 
Transfected cells were washed once with 1× PBS and then lysed in 12.6 μl of 1× 
passive lysis buffer (PLB; Promega), and light emission was measured following 
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injection of 50μl of each luciferase substrate buffer. The product of the upstream 
Renilla luciferase gene reflects zero-frame translation. Synthesis of the downstream 
firefly luciferase is dependent on frameshifting when the ORF1 stop codon is in the 
ribosomal A-site. Therefore, for each data point firefly translation activity was 
normalized relative to the Renilla activity. Data was obtained from three 
independent transfection experiments each performed in triplicate. The 9 data points 
for each construct were averaged and standard deviations calculated. The 
frameshifting efficiency (calculated as a percentage) is obtained by comparing 
firefly to Renilla activity ratio of each antizyme cassette to its corresponding in-
frame control cassette.  
S. pombe strains and culture.  
S. pombe WT strain h-s leu1-32 ura4 ade6-210 was used in these experiments. 
Plasmids were prepared from Escherichia coli strain DH5-α and were transformed 
by a standard electroporation protocol. Edinburgh Minimal Medium (EMM), 
Complete Medium Supplement (CSM) and CSM-uracil were all purchased from 
Sunrise Science Products, San Diego, USA. 
Assay of β-galactosidase activity in S. pombe. 
The method described by Guarente (Guarente, 1983) was essentially used to assay 
the β-galactosidase activity in S.pombe.  For each experiment three single colonies 
of each construct were analyzed. The experiments were performed in two or three 
independent replicas. As for the dual luciferase assay, the frameshift efficiencies 
were calculated as percentage by comparing the activities of the antizyme cassettes 
to the activities of their corresponding in-frame controls.    
In vitro transcription 
Capped and polyadenylated mRNAs were transcribed in vitro by T7 RNA 
polymerase (Wu et al., 2007) using DNA fragments generated from 2 rounds of 
PCR (see list of PCR primers). The yield of RNA was quantified using 
ImageQuantTL by comparison to known amounts of standard markers using 
ethidium bromide-stained agarose gels imaged with a GE Typhoon Trio 
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phosphorimager. Plasmid pPR301 was linearized with EcoRI to use as template for 
mRNA synthesis (Wu et al., 2007). 
Primer-extension inhibition (toe-print) assays. 
For toe-printing N. crassa ribosomes in cell-free extracts that were synthesizing 
nascent peptides containing the partial antizyme domain, translation reaction 
mixtures (10 µl) supplemented with 0, 10, or 50 µM of spermidine were 
programmed with 60 ng of mRNA and incubated at 26°C for 10 min. As controls, 
Luc mRNA containing wild-type AAP uORF was translated in the presence of 10 
µM or 2 mM Arg. Cycloheximide was added to translation reactions at a final 
concentration of 0.5µg/µl before the incubation started or at the end of the 
incubation. Toe-print assays were performed as described (Wei et al., 2012). 
 
4.3 Results 
4.3.1 Comparative sequence analysis. 
 
Intending to probe putative regulatory cis-acting sequences using a comparative 
genomics approach, we assembled sequences from additional Basidiomycota species 
(see Methods). The current present set contains 55 such antizyme mRNA sequences 
(Fig. 4.1). One of the sequences was partial and was used only for the analysis of the 
5’conserved region.  
Comparative sequence analysis of the 5’conserved region            
Comparison of the 55 Basidiomycota sequences from the current set revealed that 
the 5' conserved element was present in all 34 sequences from Agaricomycetes class 
as well as in one sequence from class Dacrymycetes of Agaricomycotina. However, 
antizyme sequences from the class Tremellomycetes of Agaricomycotina, as well as 
all the sequences of species outside of Agaricomycotina subphylum, did not show 
similarity at the amino acid level in the vicinity of the shift site and were excluded 
from further analysis of the 5’ sequence. Consequently, the 35 antizyme sequences 
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were employed for the current analysis of the 5' conserved element. The sequence 
from Dacryopinax sp. class Dacrymycetes represents the maximum sequence 
divergence.  Nucleotide and amino acid sequence alignments were used to generate 
respective sequence logos for ORF1, (Fig. 4.1A).  All Agaricomycetes antizyme 
mRNA sequences analyzed plus the sequence from Dacrymycetes have the 
frameshift site UUU-UGA. 
 Analysis of the 35 sequences confirms the previous observation that within 
the region 5’ adjacent to module A, there is high conservation at the peptide level 
(Fig. 4.1A) accompanied by synonymous substitutions in the corresponding codons 
at their third positions (note downward pointing arrows in Fig. 4.1A). The situation 
with module A itself is considered below. Additional conservation, previously 
unnoticed, is observed further upstream. Prominent among the other conserved 
features in ORF1 are two adjacent codons, encoding absolutely conserved Ala and 
Val, which show a high rate of synonymous substitutions. Another feature contained 
within the first half of ORF1 is a region of approximately 50 nucleotides, 29 of 
which are absolutely conserved. This region appears conserved at the nucleotide 
level and the most conserved nucleotides potentially form an RNA stem with 14 
base-pairs and predicted stability of at least 30 kcal/mol (Fig. 4.1A).  
 
Comparative analysis of the 3’ RNA putative stimulatory structure 
The new analysis revealed that a 3’ structure that is homologous to the one identified 
in Agaricomycotina can be formed in a number of antizyme mRNA sequences 
belonging to two other subphyla of Basidiomycota. The broad distribution of this 
putative stimulator suggests its importance in many antizymes from Basidiomycota. 
54 antizyme sequences having the first 72 nucleotides of ORF2 were aligned to 
show the conservation in the region encoding the putative secondary structure (Fig. 
4.1B, C) 
Antizyme sequences from the class Tremellomycetes of Agaricomycotina 
(e.g. the “yeast-like” human pathogen Cryptococcus neoformans) did not seem to 
possess similar structure folding potential and were excluded from further analysis 
of the 3’ putative structure.  
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The 3’ structure in sub-phyla Ustilaginomycotina and Pucciniomycotina is 
similar to the one already published for Agaricomycotina (Fig. 4.1B, C). There are 
extensive co-variant changes in stem 2. Stem 2, especially in antizyme mRNAs from 
Ustilaginomycotina and Pucciniomycotina, has several bulged nucleotides or 
nucleotide mismatches. No mismatches and very few co-variations are present in 
stem 1 from Agaricomycetes but the sequences from non-Agaricomycotina species 
show numerous co-variations. In all the sequences but one, there is no break in base-
pairing at the junction between stem 1 and stem 2 which is consistent with the 
previous suggestion that they may co-axially stack on each other.   
All examined Basidiomycota sequences, possessing the putative RNA 
structure, contain an absolutely conserved four nucleotide sequence AAAU abutting 
the 5’ end of stem 1. The corresponding region appears to be unstructured but might 
be part of unconventional ternary interactions. 
The sequence of loop 1 is highly variable, both in composition and length. It 
can be as short as 3 nucleotides, as in Piriformospora indica, or as long as 28 
nucleotides, as in Fomitiporia mediterranea. By contrast, the sequence of loop 2 is 
the most highly conserved region within the potential 3’ structure. Six out of the 
seven nucleotides that comprise the loop are absolutely conserved. The loop has 
features suggesting it may exist in something other than a single-stranded state 
(Ivanov and Matsufuji, 2010, Ivanov and Atkins, 2007) similar to previously 
published RNA triloop structures (Mitrasinovic, 2006). 
 
4.3.2 Experimental analysis: Polyamine levels and degree of relevance of 
sequence flanking the putative nascent peptide encoding signal 
 
Previously our lab developed a protocol for a fine manipulation of the polyamine 
levels in mammalian HEK293T cells (Howard et al., 2001). The lowest polyamine 
levels were achieved by pre-treatment of HEK293T cells with D,L-alpha-
difluoromethylornithine (DFMO) which is an irreversible inhibitor of ODC (Pegg, 
2006). DFMO pre-treatment, combined with adding polyamines to the media, allows 
controllable manipulation of free polyamine levels (Howard et al., 2001). Based on 
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preliminary titration experiments with spermidine (SPD) (data not shown) three data 
points were chosen for most experiments presented here: DFMO treatment alone, 
DFMO plus 50 μM SPD and DFMO plus 2 mM SPD.  
 We designed frameshift cassettes based on the sequence of Coprinopsis 
cinerea antizyme mRNA which were cloned between Renilla and Firefly luciferase 
with antizyme ORF1 in-frame with Renilla and Firefly in-frame with antizyme 
ORF2 (Figs.4.2 and 4.3). The WT cassette (WT) contains the full sequence of both 
ORFs. The antizyme sequence in a construct termed ShortWT starts at the 5’ end of 
the putative nascent peptide encoding sequence and extends to the 3’ end of the 
conserved RNA structure 3’ of the frameshift site (Figs.4.2 and 4.3)  
In the context of the WT cassette, deletion of sequence from the 3’ end of 
ORF2 up to that specifying the 5’ end of the structure 3’ of the shift site (WT 3’STR 
DEL) yielded 19.7% frameshifting efficiency with DFMO plus 50 μM SPD 
treatment. This resulted in 1.9 fold reduction compared to WT levels (38%) 
(Fig.4.3). Also in the context of the WT cassette, a deletion from the 5’ end of ORF1 
to the 3’ nt of the region encoding the putative nascent peptide signal (WT NP DEL) 
yielded 3.2% frameshifting efficiency with DFMO plus 50 μM SPD treatment. This 
is a 12 fold reduction compared to WT. 
In the context of ShortWT, the corresponding deletion of the structure 3’ of 
the shift site (3’STR DEL), or of the putative nascent peptide encoding sequence 
(NP DEL), were tested with DFMO plus 50 μM SPD treatment, yielding 
frameshifting levels of 13% and 1.8% respectively. Compared to their control, in 
this case ShortWT, these levels involve the same reduction, 1.7 and 12 fold, as their 
counterparts in full length WT context (Figs.4.2 and 4.3). (The frameshifting 
efficiency of ShortWT is 22%.)  The results suggest that the region specifying both 
the putative nascent peptide signal and the 3’RNA structure, has the same capacity 
to enhance frameshifting levels in the context of full length WT and ShortWT.  
However, the absolute frameshifting efficiency values of WT and its 
derivative constructs WT 3’STR DEL and WT NP DEL, were higher compared to 
those of ShortWT and its derivative constructs 3’STR DEL and NP DEL 
respectively. In addition the fold difference was dependant on polyamine 
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concentrations. When comparing WT and ShortWT FS efficiencies, with DFMO 
treatment alone a reduction of 3.1 fold was observed; with DFMO plus 50 μM SPD 
treatment - 1.7 fold and DFMO plus 2 mM SPD - 1.2 fold (Fig.4.3, compare WT 
and ShortWT). The results suggest that there are additional stimulatory elements 
other than the regions encoding the putative nascent peptide signal and the 
conserved 3’RNA structure which are not present in ShortWT. A detailed 
exploration of proximal and distal stimulatory elements is outside the scope of the 
present study which focuses mainly on the effect of the putative nascent peptide 
signal on frameshifting in the context of ShortWT. 
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Figure 4.3: Establishing the boundaries of the 5’ and 3’ stimulatory elements of C. 
cinerea antizyme mRNA from tests in HEK293T cells. The WT construct contains the 
full length ORF1 and ORF2 of the C. cinerea antizyme mRNA. The WT 3’STR DEL 
construct contains full length ORF1 but has a deletion starting 19 nucleotides 3’ of 
the shift site that includes the putative 3’RNA structure. The WT NP DEL construct 
has a full length ORF2 but the sequence encoding the conserved nascent peptide 
was deleted, leaving intact the sequence of module A and the shift site. The ShortWT 
construct contains the last 42 nucleotides of ORF1, including the sequence coding 
for the conserved nascent peptide, the sequence of module A and the shift site, and 
the first 64 nucleotides of ORF2 including the putative 3’RNA structure. 3’STR DEL 
construct is a derivative of ShortWT with the region encoding the putative 3’RNA 
structure deleted. NP DEL construct is another derivative of ShortWT wherein the 
sequence encoding the putative nascent peptide signal was deleted. All constructs 
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were tested in three conditions: DFMO treatment (black bars), DFMO treatment 
plus 50 µM SPD (grey bars) and DFMO treatment plus 2 mM SPD (light grey bars). 
 
 
 One of the additional frameshift cassettes based on ShortWT had both 
regions encoding the putative nascent peptide signal and the 3’RNA structure 
deleted but retained module A (5’ of the shift site), the shift site and 19 nts 3’ of the 
shift site. This yielded 0.4% frameshifting with DFMO + 50 μM SPD treatment 
which is a 57 fold reduction compared to ShortWT (Fig. 4.4A, NP+STR DEL). With 
the same treatment, a derivative of ShortWT in which the sequence of module A 
was substituted with its complement, yielded 0.6% frameshifting, a 38 fold 
reduction (Fig. 4.4A, MOD A).   
 To obtain the frameshift efficiencies of the ShortWT and its derivatives in 
cells with endogenous polyamine concentrations, we tested the cassettes from 
Fig.4.4A as well as the 3’STR DEL cassette from Fig.4.3 in mammalian HEK293T 
cells where the polyamine levels were not manipulated (Fig. 4.4C). ShortWT 
yielded a frameshift efficiency of 26% and its derivative with the 3’RNA structure 
deleted yielded a frameshift efficiency of 13% (Fig.4.4C, 3’STR DEL). NP+STR 
DEL and MOD A exhibited greatly reduced frameshift efficiencies, 0.8% and 0.5% 
respectively (Fig. 4.4C).  
 The frameshifting levels with ShortWT and its derivatives tested in cells 
treated with DFMO + 50 μM SPD closely matched the frameshifting levels obtained 
in HEK293T cells with endogenous polyamine levels (see Fig 4.4B,C). This 
observation suggested that the DFMO + 50 μM SPD treatment brings free 
intracellular polyamines close to their endogenous levels. In addition, DFMO + 50 
μM SPD supported the greatest difference in frameshifting efficiency between 
ShortWT and its derivative constructs. 
The mammalian HEK293T cell culture is a heterologous system for the 
analysis of regulatory frameshifting in the decoding of fungal antizyme mRNAs. 
The ShortWT and its derivative frameshift cassettes (Fig.4.4A) were also fused to 
the +1 frame of lacZ and transfected in S.pombe cells. When tested in the S. pombe, 
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β-galactosidase assays extrapolate to 16.5% frameshifting with the ShortWT 
(Fig.4.4D) (compared to 26% in HEK293T cells). Deletion of the 3’RNA structure 
in 3’STR DEL yielded 4.4% frameshifting efficiency, a 3.75 fold reduction 
compared to ShortWT. As with HEK293T cells, the two other constructs, NP+STR 
DEL and MOD A exhibited dramatically reduced frameshifting efficiencies: double 
deletion of the putative nascent peptide encoding signal and the 3’RNA structure 
produced a 22 fold reduction with frameshift levels of 0.74% (Fig.4.4D, NP+STR 
DEL). In the ShortWT derivative, changing the module A sequence to its 
complement yielded a 25 fold reduction with frameshift levels of 0.67% (Fig.4.4D, 
MOD A).  
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Figure 4.4 Assessing the role of the conserved sequences on frameshifting from tests 
in HEK293T cells and S. pombe. A. Schematic representation of ShortWT and its 
derivative cassettes used in 4.4B, C and D. ShortWT, 3’STR DEL and NP DEL are 
as described in Fig.4.3. The nucleotide sequences of module A and the shift site are 
indicated. The amino acid sequence of the putative nascent peptide signal (boxed) is 
shown instead of the nucleotide sequence encoding it. The NP+STR DEL construct 
has both sequences encoding the putative nascent peptide signal and the 3’RNA 
structure deleted so that it contains only the 30 nucleotide sequence surrounding the 
frameshift site. The MOD A construct has the sequence of module A changed to its 
complement; the altered sequence is in red. The NP OF construct has the sequence 
coding for the nascent peptide put out-of-frame by deleting a nucleotide (U) at the 5’ 
end of the sequence and inserting a nucleotide (G) at its 3’ end. The altered nascent 
peptide sequence is boxed in grey. B. Frameshift efficiencies of ShortWT and its 
derivative constructs tested in HEK293T cells treated with DFMO and 
supplemented with Spermidine (SPD). The constructs were tested in three 
conditions: DFMO treatment only (black bars), DFMO treatment plus 50 µM SPD 
(grey bars) and DFMO treatment plus 2 mM SPD (light grey bars). C. Frameshift 
efficiencies of ShortWT and its derivative constructs tested in HEK293T cells where 
the polyamine content was not manipulated. D. Frameshift efficiencies of ShortWT 
and its derivative constructs tested in S.pombe. 
 
4.3.3 The putative nascent peptide signal 
 
To probe the effect of the putative nascent peptide signal, the sequence encoding it 
was either deleted (NP DEL) or placed out-of-frame by deleting one nucleotide in 
the beginning of the sequence and inserting one nucleotide after it (NP OF) (Fig 
4.4A). Both alterations were done in the context of ShortWT i.e. retaining the 
previously identified structure 3’ of the shift site. They were tested in mammalian 
cells and S. pombe. Corresponding great reductions, 9 and 13 fold for NP DEL and 
18 and 26 fold for NP OF, in frameshift levels were observed in the two systems 
respectively (Fig. 4.4C &D). A similar effect was observed in HEK293T cells with 
manipulated polyamine levels, with the greatest fold difference being obtained with 
DFMO + 50 μM SPD (Fig. 4.4B). 
 To further test if the phylogenetically conserved 5’ stimulator within 
ShortWT functions at the amino acid or nucleotide levels, an additional cassette was 
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generated. In this construct, NP SYN, the sequence of the encoded peptide was 
preserved, but the nucleotide sequence encoding it was altered at the 3
rd
 base of 11 
codons by introducing synonymous substitutions. ShortWT, NP Del, NP OF and NP 
SYN were then tested in a SPD titration experiment. Synonymous substitutions had 
little effect on frameshifting efficiencies compared to ShortWT through most SPD 
supplementation concentrations tested (Fig. 4.5A). Even in the SPD concentration 
range where there was some difference – 10-500 μM – the frameshifting efficiencies 
of NP SYN were closer to ShortWT than to NP DEL or NP OF. Complete deletion 
of the sequence (NP DEL), and its out-of-frame variant (NP OF) resulted in similar 
greatly reduced frameshifting efficiencies throughout the concentration gradient. 
These results provide further evidence that high frameshifting efficiency depends on 
the peptide sequence (nascent peptide signal) rather than on its encoding nucleotide 
sequence. Additionally, the results show that with the NP DEL and NP OF cassettes, 
there is a lag in SPD stimulation of frameshifting in the first half of the titration 
gradient, compared to the pattern observed with ShortWT and NP SYN. Towards 
the later part of the gradient this pattern is reversed. This is illustrated by plotting the 
ratio of ShortWT to NP DEL frameshifting levels. This ratio was ca. 5 at the lowest 
concentrations of spermidine and peaks at ca. 19 with cells treated with DFMO and 
supplemented with 1 μM to 50 μM spermidine. It then declines at the highest 
concentrations of SPD (Fig. 4.5A). Interestingly, the position of the peak in the 
frameshifting lag coincided with the range of spermidine supplementation that 
corresponds to endogenous levels of free polyamines in HEK cells.  
Titration experiments with another main cellular polyamine, spermine 
(SPM), and with putrescine (PUT), were also performed. The peak of the ratio of 
ShortWT to NP DEL frameshifting levels with spermine was at DFMO plus 1-2.5 
μM SPM and with putrescine it was at DFMO plus 2.5 μM PUT (Fig. 4.5B, C).   
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Figure 4.5: Titration of polyamines with ShortWT and 5’ mutant cassettes. 
ShortWT, NP DEL and NP OF constructs are as described in Figs.4.3 and 4.4. The 
NP SYN construct introduces 11 synonymous changes in the sequence encoding the 
putative nascent peptide signal. The leftmost white column in each graph represents 
the frameshift level with ShortWT cassette in untreated cells - i.e. cells in which free 
polyamines are in homeostasis. The curve represents the ratio of ShortWT to NP 
DEL frameshifting across the titration gradient. A. Titration of Spermidine (SPD) 
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with ShortWT (white columns), NP DEL (grey columns), NP OF (black columns) 
and NP SYN (striped columns). B. Titration of Spermine (SPM) with ShortWT (white 
columns), NP DEL (grey columns) and NP OF (black columns). C. Titration of 
Putrescine (PUT) with ShortWT (white columns), NP DEL (grey columns) and NP 
OF (black columns). 
 
 
The contribution of individual amino acids of the nascent peptide to the 
stimulatory effect on frameshifting was assessed by testing three series of constructs. 
In an alanine scan series, each codon of the conserved peptide sequence (from 
position -15 to -5) was sequentially replaced with an alanine codon (each had an in-
frame control). None of the individual alanine substitutions produced a dramatic 
effect on frameshifting efficiency, suggesting that amino acid identity at any one 
position is not crucial (Fig.4.6A). The second, or deletion, series of constructs had a 
sequentially increasing number of codons from -15 to -2 deleted. In the third, or out-
of-frame, series increasing one codon increments from -15 to -2 of the nascent 
peptide encoding sequence were put out-of-frame. This was accomplished by 
deleting one U nucleotide at the 5’ end of the sequence and adding one U nucleotide 
at the 3’ end of each increment. The results from the series of deletion and out-of-
frame constructs are consistent with those from the alanine scan and indicate that the 
effect of residue deletion/alteration is cumulative – with progressive deletions 
yielding greater reductions of frameshifting efficiency (Fig.4.6B, C). Interestingly, 
the effect of the peptide alterations on the sensitivity of frameshifting to spermidine 
level is different with the different concentrations of SPD supplementation tested. At 
the highest concentration of SPD the frameshift site preserved a near maximum 
efficacy when the first eight amino acid residues were altered. By contrast, under 
conditions mimicking endogenous polyamine levels (DFMO + 50 μM SPD) and 
under low polyamine concentration (DFMO only), frameshifting was significantly 
reduced with as few as the first three amino acid residues being altered (Fig.4.6B, 
C). Deletion or out-of-frame mutations that encroach on module A result in dramatic 
                                                  
                                                                                
                                                                                 
 
 
103 
 
 
reduction of frameshifting efficiency, especially under condition of DFMO 
treatment plus 50 μM SPD supplementation. 
 
 
 
Figure 4.6: Fine analysis of the 5’nascent peptide stimulator. The sequence 
of the 5’ nascent peptide signal (residues -15 to -5) is shown above the figure 
highlighted in grey. The frameshifting efficiencies of three series of mutant 
                                                  
                                                                                
                                                                                 
 
 
104 
 
 
constructs are presented as percentage of ShortWT efficiency. All constructs were 
tested in three conditions: DFMO treatment (black bars), DFMO treatment plus 50 
µM SPD (grey bars) and DFMO treatment plus 2 mM SPD (light grey bars). A. 
Sequential alanine substitutions of individual codons at positions from -15 to -4; B. 
Serial deletions of codons from position -15 to -2. C. Progressive out-of-frame 
alterations of codons at positions -15 to -2. 
 
4.3.4 Nascent peptide signal and its relationship to module A 
 
To elucidate the effect of module A on frameshifting stimulation, two constructs 
with altered module A sequence were tested. The peptide signal encoding sequence 
is unaltered in MOD A in which module A sequence was substituted with its 
complement. In construct NP OF+MOD A, in addition to the module A substitution, 
the sequence of codons -15 to -5 that encode the nascent peptide signal, is placed 
out-of-frame. When tested under the three SPD supplementation conditions, 
frameshifting efficiencies with both, NP OF+MOD A and MOD A constructs, were 
dramatically lower compared to those with ShortWT or NP OF (Fig. 4.7A). This 
suggests that the peptide sequence alone is insufficient for high levels of 
frameshifting or conversely that module A is essential for efficient frameshifting.  
To investigate if module A extends 7 nucleotides 5’ of the frameshift site, as 
previously suggested (Ivanov and Atkins, 2007), we designed three constructs 
introducing nucleotide substitutions within the codon at position (-4) relative to the 
stop codon. The third nucleotide position in this codon, a G nucleotide, is the first 
nucleotide of module A, as proposed (Ivanov and Atkins, 2007). In the GGG(-
4)GGC cassette the third nucleotide of this codon was changed from the wild-type G 
to C, a substitution which preserved the identity of the encoded amino acid (Gly). 
The other two constructs tested at the same time, have Glu at position (-4), however 
in the GGG(-4)GAG construct the Glu was encoded by a GAG codon, whereas in  
GGG(-4)GAA – it was encoded by a GAA codon. We chose to substitute the native 
(Gly) with (Glu) because in at least two mushroom antizyme mRNAs, the naturally 
occurring codon at position -4 is GAG Glu instead of GGG Gly. This amino acid 
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change does not change the identity of the nucleotide at position 3. With SPD 
supplementation mimicking endogenous levels of polyamines, the construct, GGG(-
4)GAA, yielded a frameshifting efficiency closer to that of the GGG(-4)GGC 
construct, while the construct GGG(-4)GAG yielded a frameshifting efficiency 
similar to that of ShortWT (Fig.4.7B). The results suggest that the identity of the 
nucleotide at position 3 of codon -4 is more important than the identity of the amino 
acid encoded, consistent with it being part of the nucleotide specific module A. The 
nucleotides in the 5’ adjacent codon, UGG (Trp), cannot be changed without 
changing the amino acid identity at this position and so precluding this type of 
analysis. 
The codon at position (-2) was altered to test if it functions at the nucleotide 
or amino acid levels. Cassettes CGU(-2)CGA and CGU(-2)AGA introduced one and 
two nucleotide substitutions respectively, but both encode Arg which is the wild 
type amino acid at that position (-2). Both constructs yielded reduced frameshifting 
levels with the one having 2 nucleotide substitutions exhibiting a greater reduction 
(Fig.4.7B).  The greatest effect was seen with DFMO + 50 μM SPD 
supplementation – frameshifting reduced to 60% (CGU(-2)CGA) and 36% (CGU(-
2)AGA) of ShortWT. We also tested the construct CGU(-2)UGG which has two 
nucleotide substitutions that change the identity of the original Arg to Trp. This is a 
naturally occurring variation at codon (-2) in some Basidiomycotal antizyme 
mRNAs. Curiously, this alteration did not change the wild type FS levels.  
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Figure 4.7: Testing the effect of module A on antizyme frameshifting. ShortWT, NP 
OF and MOD A constructs are described in Fig.4.3 and 4.4A. The constructs were 
tested in three conditions: DFMO treatment (black bars), DFMO treatment plus 50 
µM SPD (grey bars) and DFMO treatment plus 2 mM SPD (light grey bars). A). 
NP+MOD A construct combines an out-of-frame nascent peptide encoding sequence 
and a module A sequence that is the complement of its WT. B). Frameshifting 
efficiencies with ShortWT and its derivative cassettes with nucleotide substitutions in 
the codons at positions (-4) or (-2). The GGG(-4)GAG and GGG(-4)GAA constructs 
have the glycine codon (GGG) at position -4 changed to the glutamate (GAG) or 
(GAA) codon , either by one or two nucleotide substitutions respectively. The GGG(-
4)GGC cassette has the third G nucleotide of that codon changed to C. This 
synonymous substitution preserves the identity of the encoded amino acid glycine. In 
CGU(-2)CGA construct the third nucleotide (U) in the CGU (Arg) codon at position 
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-2 is changed to an (A). CGU(-2)AGA has two nucleotide changes which however 
do not alter the encoded amino acid (Arg). In CGU(-2)UGG construct the CGU 
(Arg) codon at position -2 is changed to UGG (Trp) codon.  
 
 Finally we tested the potential of the stimulatory nascent peptide and module 
A in ShortWT context to cause a pause that is detectable  using a toe-printing assay 
in Neurospora crassa extracts (Wang and Sachs, 1997). The positive control was the 
Arginine Attenuator Peptide (AAP) encoding sequence in the presence or absence of 
externally added Arg (Wang and Sachs, 1997) (Fig.4.8). Stalling was not observed 
with the antizyme cassette under the conditions tested. Toe-printing with 3’STR 
DEL construct, and its derivative with the U of the stop codon deleted, in rabbit 
reticulocyte lysate (RRL) gave a similar result (Fig.4.9).  
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Figure 4.8. Toe-printing of ribosomes translating C. cinerea antizyme mRNA in N. 
crassa extracts. The mRNAs used to program translation in N. crassa extracts are 
indicated on the top. On the left, reaction mixtures contained 10 µM (−) or 2 mM 
(+) Arg and 10 µM each of the other 19 amino acids. On the right, reaction 
mixtures contained 10 µM of the 20 amino acids and 0, 10, or 50 µM of spermidine 
(SPD). Cycloheximide was added to the reactions at indicated time points. Lanes 
indicated as no RNA or no EXT show toe-printing of extract without added RNA, 
and of RNA in the absence of extract, respectively. The same primer was also used 
for dideoxynucleotide sequencing of pRR301 (left sequencing markers) and 
pShortWT-IF (right sequencing markers). The open circles indicate the position of 
the toe-prints corresponding to ribosomes with the initiation AUG codon in the P-
site. The black arrowhead indicates the position of the toe-prints corresponding to 
ribosomes with the AAP uORF termination codon in the A-site. The open arrowhead 
indicates the position of the G nucleotide in the ORF1 stop codon of ShortWT. 
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Figure 4.9: Toe-printing of 3’STR DEL and 3’STR DEL IF mRNAs in rabbit 
reticulocyte lysate (RRL). Translation conditions are labelled on the top of the gel. 
The open circle indicates the main initiation signal at the AUG. The position of the 
G nucleotide in the shift site is indicated by an open arrowhead. 
 
4.4 Discussion 
 
4.4.1 Nascent Peptide. 
  
The results provide experimental and further phylogenetic evidence for a nascent 
peptide stimulator of Agaricomycetes antizyme mRNA +1 frameshifting. When the 
sequence encoding the 11 AA peptide (encoded -15 to -5 codons 5’ of the shift site) 
is placed out-of-frame, frameshifting is reduced similarly to that of a complete 
deletion. In contrast, compared to wild type, introducing 11 synonymous nucleotide 
changes in the same region had a small effect on frameshifting. Serial 5’ deletions, 
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out-of-frame mutations and an alanine scan (Fig. 4.6) suggest that the contribution 
of the amino acids to the effect is cooperative with no single amino acid being 
crucial for the stimulatory effect.  
 In distinction to the nascent peptide signal effects in S. cerevisiae, the 
peptide signal described here acts within the ribosome mediating the frameshift 
event. The 11 AA long peptide signal is expected to occupy approximately one third 
of the peptide exit tunnel. It is longer than MAGDIS, the hexapeptide product of the 
inhibitory uORF in mammalian AdoMetDC mRNA (Mize et al., 1998), but 
substantially shorter than the nascent peptide signal responsible for StopGo/Stop-
Carry on (Donnelly et al., 2001a). Atomic level structure analysis of S. cerevisiae 
ribosomes reveal a constriction in the exit tunnel (Yusupova and Yusupov, 2014), 
that is the counterpart of that in bacteria at which SecM works – in bacteria this is 
approximately one third of the way into the tunnel from the PTC. Because of 
positioning of the Agaricomycete nascent peptide signal beginning 3AA distant 
from the PTC at the time of frameshifting, it may span the constriction likely also 
present in its ribosomes.  
  Small molecules, other than polyamines, can influence nascent peptide 
effects more generally within the peptide exit tunnel and an increasing number of 
examples are known where a specific nascent sequence in the exit tunnel causes a 
ribosome stall in eukaryotes (Luo et al., 1995, Wei et al., 2012) and in bacteria 
(Vazquez-Laslop et al., 2010, Gong and Yanofsky, 2002). In some cases (Cao and 
Geballe, 1996), the ribosome stalling occurs just prior to, or during, the decoding of 
a stop codon in the ribosomal A site, such that termination is inhibited. Since 
frameshifting and other recoding events are in competition with standard decoding, 
inhibition of the standard decoding step should push the equilibrium toward the 
recoding event (Atkins and Gesteland, 2010).  
 The results from the toe-printing assay could reflect instability of the 
particular stalled complex involved even though the counterpart paused complex in 
the positive control was stable. However it is more likely that at the sensitivity of the 
assay, no detectable pausing occurs. The peptide effect might not be due to ribosome 
stalling. If so, it would be conceptually similar to one case in bacteria recently 
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identified where ketolides promote -1 frameshifting when translating the leader 
peptide that results in activation of the translation of the downstream gene (Gupta et 
al., 2013). Recently highly sensitive single-molecule fluorescence has been applied 
to study the dynamics of a 5’ stimulatory element on bacterial -1 frameshifting 
(Chen et al., 2014). As FRET approaches are developed for counterpart studies in 
eukaryotes much more refined step time data should be forthcoming.  Knowledge of 
the likely non-canonical ribosome states in antizyme frameshifting are likely from 
such studies and other approaches especially cryo Electron Microscopy. 
 The results presented here, suggest that the role of the Agaricomycetes 
nascent peptide stimulators, presumably via interaction with exit tunnel components, 
is not simply to increase the efficiency of frameshifting but also to contribute to 
making the process especially sensitive to intracellular free polyamines at their 
endogenous levels. This is a novel feature for the function of cis-acting sequences in 
antizyme mRNA frameshifting.  
  
4.4.2 Polyamine level.  
 
Previous analyses of cis-acting stimulators of frameshifting in antizyme genes were 
usually performed in a way that only examined their effect in two extreme 
conditions with regard to polyamine concentrations – cells depleted for polyamines 
and supplemented with the highest dose of polyamines. This approach fails to 
investigate what function the cis-acting stimulators might have in intermediate 
concentrations of polyamines much closer to their endogenous levels. This approach 
fails to investigate what function the cis-acting stimulators have in intermediate 
concentrations of polyamines closer to their endogenous levels. When a spermidine 
titration experiment was performed with a wild type construct and three mutant 
constructs affecting the nascent peptide stimulator, a significant result was observed. 
The mutant constructs that substituted the amino acid sequence of this region 
exhibited a response lag to polyamine stimulation – i.e. intermediate concentrations 
of polyamines stimulate the wild type and the synonymous mutants far more than 
they do the two mutants that change the amino acid sequence of the nascent peptide 
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(Fig. 4.5A). The point on the titration experiment where the difference in stimulation 
is greatest coincides with the DFMO + polyamine supplementation that induces 
frameshifting levels in ShortWT close to 22%. This is very close to the 
frameshifting observed with the same sequence in untreated cells. In other words, 
the difference in response to polyamines between mutant cassettes that do, or do not, 
encode altered peptide sequence, is greatest under conditions that most closely 
mimic endogenous levels of free polyamines. This suggests that the sensor function 
of the nascent peptide stimulator is physiologically relevant. The potential for 
differential affinity sites for polyamine binding with contrasting effects on 
frameshifting makes it likely that discerning the mechanism will not be a simple 
task.  
4.4.3 Module A 
 
One of the 5’ stimulators of antizyme frameshifting, apparently present in many if 
not most antizyme homologs, is a sequence of 6 to 7 nucleotides immediately 
abutting the shift site. At the time of the frameshifting the 5’ adjacent codon to the 
shift site UUU_U would be in the E-site or in transit. Prior studies with different 
types of frameshifting have shown the importance of E-site codon interactions in 
some cases (Sanders and Curran, 2007, Baranov et al., 2002a, Leger et al., 2007). In 
Agaricomycete antizyme mRNA the E-site codon position with the greatest 
variability is definitely the third position (Fig. 1A). Experimentally changing the 
CGU (Arg) to CGA (Arg) or AGA (Arg) reduced frameshifting at all polyamine 
concentrations tested, with two changes leading to more severe reduction. In some 
Basidiomycotal antizyme mRNAs, outside of the Agaricomycetes lineage, there is a 
natural variation at the same codon, -2, that replaces the CGU Arg with UGG Trp. 
Substituting CGU with UGG, involving the same two codon positions did not 
reduce frameshifting at any of the polyamine concentrations tested. This is 
consistent with the overall strength of E-site codon:anticodon, irrespective of 
individual nt position, being relevant but is a weak inference.  
 Changing codon -4 from GGG (Gly) to GAG (Glu) had no effect on the 
efficiency, but changing it to GAA (Glu) resulted in a 40% reduction and to GCG 
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(Ala) had a 50% reduction. These data raise the possibility that the encoded amino 
acid may have an effect in the peptide exit tunnel and the nucleotide sequence may 
have an effect with the mRNA exit tunnel, perhaps even in interactions with rRNA.   
Mutating module A to its complementary sequence had the same lag effect 
on polyamine stimulation across a titration gradient as seen with the nascent peptide 
mutants. Though the number of data points was limited (Fig. 4.7A), this suggests 
that module A too could be involved in sensitizing the shift site to polyamines in 
their endogenous levels range.  As introduced above, module A is widely 
evolutionarily conserved and its original likely predates that of the nascent peptide 
signal in Agaricomycetes which has a restricted range. Though module A and the 
nascent peptide signal work at the same time, it may well be that future work will 
reveal instances of programmed frameshifting where the only 5’/5’ encoded 
stimulator is a nascent peptide signal. The involvement of nascent peptide signals in 
stop codon readthrough, a different class of recoding, is also to be expected. 
The experiments examining the mode of function of the conserved elements 
in Agaricomycetes antizyme mRNAs revealed that in addition to their stimulatory 
effect on the frameshift efficiency, these elements seem to sensitize the frameshift 
site for polyamines especially in the range of their endogenous concentrations. This 
model provides an example for how the cis-acting elements in antizyme mRNAs 
could exert their function.
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